Disease,Category,Chakra,Nphenotype,Ngenes,Elite,Inheritance,Nvariants,Phenotype,Gene,Promoter,Malacards
Wilson Disease,endocrine,ritu,62,1,yes,autosomal recessive  ,311,Nervous system,ATP7B,CCTTCCATGCTGTGTGTGGCCCTCAGATATTCTGCCCGCTAAGCGCAAACATAGTGCTTTAGCTTGGTTTAAATGGCACTTTATTGCAGCTTTCCTGCCCCACCCAGG,"Wilson disease (WD) is a rare inherited disorder in which an excessive amount of copper accumulates in the body. The buildup of copper leads to damage in the liver, brain, and eyes. Although copper accumulation begins at birth, symptoms of the disorder only appear later in life. The most characteristic sign of WD is the Kayser-Fleisher ringâ€”a rusty brown ring around the cornea of the eye that can best be viewed using an ophthalmologist's slit lamp. The primary consequence for most individuals with WD is liver disease, appearing in late childhood or early adolescence as acute hepatitis, liver failure, or progressive chronic liver disease in the form of chronic active hepatitis or cirrhosis of the liver."
Adult Polyglucosan Body Disease,endocrine,ritu,27,1,yes,autosomal recessive  ,4,Nervous system,GBE1,TGAGCGAGGTCAGCTTGGGACCCACCTCCTAGAATGACCTCCGCCAGCAGGAAAAAACCGTTAAGGGGAGGAAAGGGCAGGTCCCTGCGGCCTCCAGGTGCCAGCCGC,"Adult polyglucosan body disease (APBD) is a condition that affects the nervous system. People with APBD typically first experience signs and symptoms related to the condition between ages 35 and 60. Initial symptoms of the disorder include numbness and tingling in the legs (peripheral neuropathy) and progressive muscle weakness and stiffness (spasticity). As a result, affected individuals can have an unsteady gait, poor balance, and an increased risk of falling. Damage to the nerves that control bladder function, a condition called neurogenic bladder, is another feature that often occurs early in the course of APBD. Affected individuals have increasing difficulty starting or stopping the flow of urine. Eventually, most people with APBD lose the ability to control their bladder and bowel functions and their limbs."
Alpha-1 Antitrypsin Deficiency,endocrine,ritu,14,1,yes,autosomal recessive  ,57,Digestive system,SERPINA1,GGCTGGTTTAATAATCCCTAGGCACTTCCACGTGGTGTCAATCCCTGATCACTGGGAGTCATCATGTGCCTTGACTCGGGGCCTGGCCCCCCCATCTCTGTCTTGCAG,"Alpha-1 antitrypsin deficiency is an inherited disorder that may cause lung disease and liver disease. The signs and symptoms of the condition and the age at which they appear vary among individuals. People with alpha-1 antitrypsin deficiency usually develop the first signs and symptoms of lung disease between ages 25 and 50. The earliest symptoms are shortness of breath following mild activity, reduced ability to exercise, and wheezing. Other signs and symptoms can include unintentional weight loss, recurring respiratory infections, and fatigue. Affected individuals often develop emphysema, which is a lung disease caused by damage to the small air sacs in the lungs (alveoli). Characteristic features of emphysema include difficulty breathing, a hacking cough, and a barrel-shaped chest."
Familial Hypercholesterolemia,endocrine,ritu,70,10,yes,autosomal dominant  ,2342,Cardiovascular system,LDLR,ACAACAAATCAAGTCGCCTGCCCTGGCGACACTTTCGAAGGACTGGAGTGGGAATCAGAGCTTCACGGGTTAAAAAGCCGATGTCACATCGGCCGTTCGAAACTCCTC,"Familial hypercholesterolemia is an inherited condition characterized by very high levels of cholesterol in the blood. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals (particularly egg yolks, meat, poultry, fish, and dairy products). The body needs this substance to build cell membranes, make certain hormones, and produce compounds that aid in fat digestion. In people with familial hypercholesterolemia, the body is unable to get rid of extra cholesterol, and it builds up in the blood. Too much cholesterol increases a person's risk of developing heart disease. People with familial hypercholesterolemia have a high risk of developing a form of heart disease called coronary artery disease at a young age."
Hermansky Pudlak Syndrome,endocrine,ritu,7,9,yes,autosomal recessive  ,3,Skeletal system,HPS6,CTCCCCCGGCGGGCGTGTAGTGTCGGCCCAGCGACTGCGGGAGGCATCCCGGAGCCGGCCGGGCGGGGCGGAGTCGACGCTCGGCCCGGCCTCTGCTCACCTCATCCA,"Hermansky-Pudlak syndrome is a disorder characterized by a condition called oculocutaneous albinism, which causes abnormally light coloring (pigmentation) of the skin, hair, and eyes. Affected individuals typically have fair skin and white or light-colored hair. People with this disorder have a higher than average risk of skin damage and skin cancers caused by long-term sun exposure. Oculocutaneous albinism reduces pigmentation of the colored part of the eye (iris) and the light-sensitive tissue at the back of the eye (retina). Reduced vision, rapid and involuntary eye movements (nystagmus), and increased sensitivity to light (photophobia) are also common in oculocutaneous albinism."
Wolfram-Like Syndrome,endocrine,ritu,27,1,yes,autosomal dominant  ,6,Nervous system,WFS1,TGATTGGCGGCTACACCGGCCACTCAGCAGGCCGAGCTGGCGCCGCATCCGGGGGGCCGCGTCTGGAGTGGAGGGAGGCCGAAGGCCCCGCCCCTGCCCCGCCCCCTC,"Autosomal dominant Wolfram-like syndrome is characterized by the clinical triad of congenital progressive hearing impairment, diabetes mellitus, and optic atrophy. The hearing impairment, which is usually diagnosed in the first decade of life, is relatively constant and alters mainly low- and middle-frequency ranges (summary by Valero et al., 2008). Wolfram syndromeis an autosomal recessive allelic disorder characterized by optic atrophy, diabetes mellitus, hearing loss, and diabetes insipidus, and is caused by homozygous or compound heterozygous mutation in the WFS1 gene."
Barth Syndrome,endocrine,ritu,28,2,yes,X-linked recessive  ,45,Head or neck,TAFAZZIN,ACGGGGTGACGGCCACTTCCCGCCGCCCCGGGGCTGGCCTCGCTGCCGTCAAGCGGCCCGTGCGCGCTTTGCGACAGTCGGTCGGGCTGGGCACCGGCGCAGGTTCGC,"Barth syndrome is a rare condition characterized by an enlarged and weakened heart (dilated cardiomyopathy), weakness in muscles used for movement (skeletal myopathy), recurrent infections due to small numbers of white blood cells (neutropenia), and short stature. Barth syndrome occurs almost exclusively in males. In males with Barth syndrome, dilated cardiomyopathy is often present at birth or develops within the first months of life. Over time, the heart muscle becomes increasingly weakened and is less able to pump blood. Individuals with Barth syndrome may have elastic fibers in place of muscle fibers in some areas of the heart muscle, which contributes to the cardiomyopathy."
Cystic Fibrosis,endocrine,ritu,21,21,yes,autosomal recessive  ,872,Immune system,CFTR,GCAAATTTGGGGCCGGACCAGGCAGCACTCGGCTTTTAACCTGGGCAGTGAAGGCGGGGGAAAGAGCAAAAGGAAGGGGTGGTGTGCGGAGTAGGGGTGGGTGGGGGG,"Cystic fibrosis is an inherited disease characterized by the buildup of thick, sticky mucus that can damage many of the body's organs. The disorder's most common signs and symptoms include progressive damage to the respiratory system and chronic digestive system problems. The features of the disorder and their severity varies among affected individuals. Mucus is a slippery substance that lubricates and protects the linings of the airways, digestive system, reproductive system, and other organs and tissues. In people with cystic fibrosis, the body produces mucus that is abnormally thick and sticky. This abnormal mucus can clog the airways, leading to severe problems with breathing and bacterial infections in the lungs."
Homozygous Familial Hypercholesterolemia,endocrine,ritu,70,6,yes,autosomal dominant  ,2342,Cardiovascular system,LDLR,ACAACAAATCAAGTCGCCTGCCCTGGCGACACTTTCGAAGGACTGGAGTGGGAATCAGAGCTTCACGGGTTAAAAAGCCGATGTCACATCGGCCGTTCGAAACTCCTC,"Familial hypercholesterolemia is an inherited condition characterized by very high levels of cholesterol in the blood. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals (particularly egg yolks, meat, poultry, fish, and dairy products). The body needs this substance to build cell membranes, make certain hormones, and produce compounds that aid in fat digestion. In people with familial hypercholesterolemia, the body is unable to get rid of extra cholesterol, and it builds up in the blood. Too much cholesterol increases a person's risk of developing heart disease."
Congenital Adrenal Hyperplasia,endocrine,ritu,422,2,yes,autosomal recessive  ,176,Genitourinary system,CYP21A2,TTCTCGATGGGTGATTAATTTTTTTTGAAATACGGACGTCCCAAGGCCAATGAGACTGGTGTCATTCCAGAAAAGGGCCACTCTGTGGGTGGGTCGGTGGGAAGGCAC,"Congenital adrenal hyperplasia (CAH) refers to a group of genetic conditions that affect the adrenal glands. These glands sit on top of the kidneys and are responsible for releasing various types of hormones that the body needs to function. Affected people lack an enzyme the adrenal glands need to make one or more of these hormones and often overproduce androgens (male hormones such as testosterone). For example, females with a severe form of the condition may have ambiguous genitalia at birth and if not properly diagnosed, develop dehydration, poor feeding, diarrhea, vomiting and other health problems soon after. People with milder forms may not be diagnosed with the condition until adolescence or adulthood when they experience early signs of puberty or fertility problems."
Familial Chylomicronemia Syndrome,endocrine,ritu,52,1,yes,autosomal recessive  ,65,Digestive system,LDLR,ACAACAAATCAAGTCGCCTGCCCTGGCGACACTTTCGAAGGACTGGAGTGGGAATCAGAGCTTCACGGGTTAAAAAGCCGATGTCACATCGGCCGTTCGAAACTCCTC,"Familial hypercholesterolemia is an inherited condition characterized by very high levels of cholesterol in the blood. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals (particularly egg yolks, meat, poultry, fish, and dairy products). The body needs this substance to build cell membranes, make certain hormones, and produce compounds that aid in fat digestion. In people with familial hypercholesterolemia, the body is unable to get rid of extra cholesterol, and it builds up in the blood."
Addisons Disease,endocrine,ritu,1051,1,yes,autosomal recessive  ,635,Genitourinary system,ABCD1,CCGGACTCCGCCCCTCGCCCCTCCTCCGCCTCCTCCCCTTCCCCCGACTCGCCCCTGGGGAAGAGTGGGTGGGGATTCTGGGCCGGTGGAGGAGTCACTGTCGCTTCA,"Autoimmune Addison disease affects the function of the adrenal glands, which are small hormone-producing glands located on top of each kidney. It is classified as an autoimmune disorder because it results from a malfunctioning immune system that attacks the adrenal glands. As a result, the production of several hormones is disrupted, which affects many body systems. The signs and symptoms of autoimmune Addison disease can begin at any time, although they most commonly begin between ages 30 and 50. Common features of this condition include extreme tiredness (fatigue), nausea, decreased appetite, and weight loss. In addition, many affected individuals have low blood pressure (hypotension), which can lead to dizziness when standing up quickly; muscle cramps; and a craving for salty foods. "
Pten Hamartoma Tumor Syndrome,endocrine,ritu,435,5,yes,autosomal dominant  ,173,Skeletal system,PTEN,CAGGCAGCTACACTGGGCATGCTCAGTAGAGCCTGCGGCTTGGGGACTCTGCGCTCGCACCCAGAGCTACCGCTCTGCCCCCTCCTACCGCCCCCTGCCCTGCCCTGC,"Bannayan-Riley-Ruvalcaba syndrome is a genetic condition characterized by a large head size (macrocephaly), multiple noncancerous tumors and tumor-like growths called hamartomas, and dark freckles on the penis in males. The signs and symptoms of Bannayan-Riley-Ruvalcaba syndrome are present from birth or become apparent in early childhood. At least half of affected infants have macrocephaly, and many also have a high birth weight and a large body size (macrosomia). Growth usually slows during childhood, so affected adults are of normal height and body size. About half of all children with Bannayan-Riley-Ruvalcaba syndrome have intellectual disability or delayed development, particularly the development of speech and of motor skills such as sitting, crawling, and walking. These delays may improve with age."
Familial Partial Lipodystrophy,endocrine,ritu,271,1,yes,autosomal dominant  ,48,Metabolism/homeostasis,LMNA,TAAATGAACTGGATGGAGCAGCATGAAACTGACGGGAGGGGGGCGCGCCGGGGGCGCCCGGGGCATGCCGGGAGTTGTAGTTTCCCGCCCTTGGGGGCGCGGGGACAA,"Familial partial lipodystrophy is a rare condition characterized by an abnormal distribution of fatty (adipose) tissue. Adipose tissue is normally found in many parts of the body, including beneath the skin and surrounding the internal organs. It stores fat as a source of energy and also provides cushioning. In people with familial partial lipodystrophy, adipose tissue is lost from the arms, legs, and hips, giving these parts of the body a very muscular appearance. The fat that cannot be stored in the limbs builds up around the face and neck, and inside the abdomen. Excess fat in these areas gives individuals an appearance described as ""cushingoid,"" because it resembles the physical features associated with a hormonal disorder called Cushing disease."
Lipoprotein Lipase Deficiency,endocrine,ritu,14,1,yes,autosomal recessive  ,42,Digestive system,LPL,GTTGAGTATTTAACGTGAATCGATGTAAACCTGTGTTTGGTGCTTAGACAGGGGGCCCCCGGGTAGAGTGGAACCCCTTAAGCTAAGCGAACAGGAGCCTAACAAAGC,"Familial lipoprotein lipase deficiency is an inherited condition that disrupts the normal breakdown of fats in the body, resulting in an increase of certain kinds of fats. People with familial lipoprotein lipase deficiency typically develop signs and symptoms before age 10, with one-quarter showing symptoms by age 1. The first symptom of this condition is usually abdominal pain, which can vary from mild to severe. The abdominal pain is often due to inflammation of the pancreas (pancreatitis). These episodes of pancreatitis begin as sudden (acute) attacks. If left untreated, pancreatitis can develop into a chronic condition that can damage the pancreas and, in rare cases, be life-threatening. Affected individuals may also have an enlarged liver and spleen (hepatosplenomegaly)."
Glycogen Storage Disease,endocrine,ritu,23,5,yes,autosomal recessive  ,217,Head or neck,GAA,GGGGGGCGTAGCGCGGACGCGCACCCTTGCCTCGGGCGCCTGCGCGGGAGGCCGCGTCACGTGACCCACCGCGGCCCCGCCCCGCGACGAGCTCCCGCCGGTCACGTG,"Glycogen storage disease type IV (GSD IV) is an inherited disorder caused by the buildup of a complex sugar called glycogen in the body's cells. The accumulated glycogen is structurally abnormal and impairs the function of certain organs and tissues, especially the liver and muscles. There are five types of GSD IV, which are distinguished by their severity, signs, and symptoms. The fatal perinatal neuromuscular type is the most severe form of GSD IV, with signs developing before birth. Excess fluid may build up around the fetus (polyhydramnios) and in the fetus' body. Affected fetuses have a condition called fetal akinesia deformation sequence, which causes a decrease in fetal movement and can lead to joint stiffness (arthrogryposis) after birth."
Amyloidosis,endocrine,ritu,191,1,no,autosomal dominant  ,144,Nervous system,TTR,CCTAACTGGTCAAATGACCTATTAAGAATATTTCATAGAACGAATGTTCCGATGCTCTAATCTCTCTAGACAAGGTTCATATTTGTATGGGTTACTTATTCTCTCTTT,"Amyloidosis occurs when abnormal proteins called amyloids build up and form deposits. The deposits can collect in organs such as the kidney and heart. This can cause the organs to become stiff and unable to work the way they should. There are three main types of amyloidosis: Primary - with no known cause Secondary - caused by another disease, including some types of cancer Familial - passed down through genes Symptoms can vary, depending upon which organs are affected. Treatment depends on the type of amyloidosis you have. The goal is to help with symptoms and limit the production of proteins. If another disease is the cause, it needs to be treated."
Hypoparathyroidism,endocrine,ritu,920,1,no,autosomal dominant  ,408,Skeletal system,PTH,GTGTGTGTATGTGCTGCTTTGAACCTATAGTTGAGATCCAGAGAATTGGGAGTGACATCATCTGTAACAATAAAAGAGCCTCTCTTGGTAAGCAGAAGACCTATATAT,"Hypoparathyroidism is is an endocrine disorder in which the parathyroid glands in the neck do not produce enough parathyroid hormone (PTH). Common signs and symptoms include abdominal pain, brittle nails, cataracts, dry hair and skin, muscle cramps, tetany, pain in the face, legs, and feet, seizures, tingling sensation, and weakened tooth enamel (in children). It may be caused by injury to the parathyroid glands (e.g., during surgery)."
Hypophosphatemic Ricketts,endocrine,ritu,242,1,yes,X linked,228,Skeletal system,FGF23,CCTCCGGGGTCTTTGCACTTTCTTTCAATGGGCTGATTACAACACAGAGGATGTGGACAGTGGAGTTTTTCCTGTTTGATGTCACACTGCTACCCTTTAAAAGTCTGA,"Hereditary hypophosphatemic rickets is a disorder related to low levels of phosphate in the blood (hypophosphatemia). Phosphate is a mineral that is essential for the normal formation of bones and teeth. In most cases, the signs and symptoms of hereditary hypophosphatemic rickets begin in early childhood. The features of the disorder vary widely, even among affected members of the same family. Mildly affected individuals may have hypophosphatemia without other signs and symptoms. More severely affected children experience slow growth and are shorter than their peers. They develop bone abnormalities that can interfere with movement and cause bone pain. The most noticeable of these abnormalities are bowed legs or knock knees."
Lipodystrophy,endocrine,ritu,1051,7,yes,autosomal recessive  ,193,Head or neck,BSCL2,CTCGGGAAGGCTCCGCCCCGTCCCGCCCCGCCCCGCCGTGCTGGACCCCGCCCTGGGCTGAAGCCCCGCCTCCCACGGCTACAAAAGCGGCCGGCGGAGAGGGGCGGG,"Congenital generalized lipodystrophy (also called Berardinelli-Seip congenital lipodystrophy) is a rare condition characterized by an almost total lack of fatty (adipose) tissue in the body and a very muscular appearance. Adipose tissue is found in many parts of the body, including beneath the skin and surrounding the internal organs. It stores fat for energy and also provides cushioning. Congenital generalized lipodystrophy is part of a group of related disorders known as lipodystrophies, which are all characterized by a loss of adipose tissue. A shortage of adipose tissue leads to the storage of fat elsewhere in the body, such as in the liver and muscles, which causes serious health problems."
Mitochondrial Disease,endocrine,ritu,8894,40,yes,maternal*,6325,Nervous system,POLG,GCTCCATTGGCGGCCCTCCTATTGGTCGCGCTGGGAGTCTCCCGCTTGCCTCTCGGGTAGCCGCGGGACCTAGCTGGGTGCAGACGGGAAGTTGCGGCTGCCAGCGAA,"Mitochondrial diseases are a group of metabolic disorders. Mitochondria are small structures that produce energy in almost all of your cells. They make it by combining oxygen with the fuel molecules (sugars and fats) that come from your food. When the mitochondria are defective, the cells do not have enough energy. The unused oxygen and fuel molecules build up in the cells and cause damage. The symptoms of mitochondrial disease can vary. It depends on how many mitochondria are defective, and where they are in the body. Sometimes only one organ, tissue, or cell type is affected. But often the problem affects many of them. Muscle and nerve cells have especially high energy needs, so muscular and neurological problems are common. The diseases range from mild to severe. Some types can be fatal. Genetic mutations cause these diseases. They usually happen before age 20, and some are more common in infants."
Porphyria 164,metaboilc,indu,299,1,no,autosomal dominant  ,153,Nervous system,HMBS,ACTTGCTCATGTCACAGCTGGGGAATGGGGTGGTCGAATGGGGAGGTCCACTGTCGCAATGTTCCAATTCCCGCCCAGAGGGAGGGACCTCCCCTTCGAGGGAGGGCG,"Porphyria is a group of disorders caused by abnormalities in the chemical steps that lead to heme production. Heme is a vital molecule for all of the body's organs, although it is most abundant in the blood, bone marrow, and liver. Heme is a component of several iron-containing proteins called hemoproteins, including hemoglobin (the protein that carries oxygen in the blood). Researchers have identified several types of porphyria, which are distinguished by their genetic cause and their signs and symptoms. Some types of porphyria, called cutaneous porphyrias, primarily affect the skin. Areas of skin exposed to the sun become fragile and blistered, which can lead to infection, scarring, changes in skin coloring (pigmentation), and increased hair growth."
Creatine Transporter Deficiency 89,metabolic,indu,54,1,yes,X-linked recessive  ,40,Nervous system,GAMT,GAGGGGGCGGCCGGGGCCCCGACCCCACTCCCGCCACCTCTCGCGTGGCCGCCGCTAGAGGCCGCTCCCGGAGCCGCGCGCGCGCGTCCTCTCGCGGGTCCGCCCCCC,"Creatine deficiency syndrome (CDS) comprises a group of inborn errors of creatine metabolism, characterized by a global developmental delay, intellectual disability and associated neurological (seizures, movement disorders, myopathy) and behavioral manifestions. CDS includes two creatine biosynthesis disorders; guanidinoacetate methyltransferase deficiency and L- Arginine: glycine amidinotransferase deficiency, as well as X-linked creatine transporter deficiency."
Primary Hyperoxaluria Type 1 94,metabolic,indu,39,1,yes,autosomal recessive  ,195,Skeletal system,AGXT,CTCAGCCCTGGGGGCTCCCTCTGCCTGAGGGCTTCGTCCCCTGCTGCCTGGCCGTGACCCGCAGCACAAGCACAGATAAGCCTCAGGGAACAAAAGGCAGGGCTGCCA,"Primary hyperoxaluria type 1 (PH1) is a rare disorder that mainly affects the kidneys. It results from buildup of a substance called oxalate, which normally is filtered through the kidneys and excreted in the urine. In people with PH1, the accumulated oxalate is deposited in the kidneys and urinary tract. It combines with calcium, forming the main component of kidney and bladder stones (calcium oxalate). Signs and symptoms of PH1 vary in severity and may begin any time from infancy to early adulthood. Symptoms may include recurrent kidney stones; blood in the urine; and urinary tract infections. PH1 is due to genetic changes in a gene called AGXT."
Cystinuria 131,metabolic,indu,11,3,yes,autosomal recessive  ,54,Genitourinary system,SLC3A1,GCGCCAGTCCCGAGATTTTTTTTTTAAACCTCTGTACTTTTACCCTTTCTTCCTTGGCTGGACTTTGTCCAGCTAGGTTTATTTATAAACCACACAAAGTTCATTAAC,"Cystinuria is a condition characterized by the buildup of the amino acid cystine, a building block of most proteins, in the kidneys and bladder. As the kidneys filter blood to create urine, cystine is normally absorbed back into the bloodstream. People with cystinuria cannot properly reabsorb cystine into their bloodstream, so the amino acid accumulates in their urine. As urine becomes more concentrated in the kidneys, the excess cystine forms crystals. Larger crystals become stones that may lodge in the kidneys or in the bladder. "
Peroxisomal Biogenesis Disorder 134,metabolic,indu,654,5,yes,autosomal recessive  ,706,Head or neck,PEX6,TACTGCCTATCGAGGCACGACGCAGATCAATCCGAGGCGCAGCTAACCCCCTCAGAGCAAGTTCGCGGCACCCGACCCCCCTCCCCTTTTCCTCTGGCCTCCCCTGAC,"Infantile Refsum disease (IRD) is a medical condition within the Zellweger spectrum of perixisome biogenesis disorders (PBDs), which are inherited genetic disorders that damage the white matter of the brain and affect motor movements. PBDs are part of a larger group of disorders called the leukodystrophies. The Zellweger spectrum of PBDs include related, but not more severe, disorders referred to as Zellweger syndrome (ZS) and neonatal adrenoleukodystrophy. Collectively, these disorders are caused by inherited defects in any one of the 12 PEX genes that are required for the normal formation and function of peroxisomes. Peroxisomes are cell structures required for the normal formation and function of the brain, eyes, liver, kidneys, and bones."
Phenylketonuria 135,metabolic,indu,88,1,yes,autosomal recessive  ,448,Nervous system,PAH,CTCTAGCTGTAGTTTTCTGAAGTCAGCGCACAGCAAGGCAGTGTGCTTAGAGGTTAACAGAAGGGAAAACAACAACAACAAAAATCTAAATGAGAATCCTGACTGTTT,"Phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. Phenylalanine is an amino acid that is obtained from eating certain foods (such as meat, eggs, nuts, and milk) and in some artificial sweeteners. If PKU is not treated, phenylalanine can build up to harmful levels in the body, causing intellectual disability and other serious health problems. The signs and symptoms of PKU vary from mild to severe. The most severe form of this disorder is known as classic PKU. Infants with classic PKU appear normal until they are a few months old. Without treatment, these children develop permanent intellectual disability. Seizures, delayed development, behavioral problems, and psychiatric disorders are also common."
Lchad Deficiency 222,metabolic,indu,29,4,yes,autosomal recessive  ,79,Skeletal system,HADHA,GGAAAACCAGGCACTCCACCCCCTCCTCTCCGGGCCCCCGTCCTCCCCCGGAGAATACGACCTTTCGGCCATGTTAGCCAGGAGCGAGGGGCAGGGCTAAGGGGCCGG,"Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a rare condition that prevents the body from converting certain fats to energy, particularly during periods without food (fasting). Signs and symptoms of LCHAD deficiency typically appear during infancy or early childhood. Many affected infants have feeding difficulties, such as an extreme dislike of certain foods or of eating at all (food or feeding aversion), nausea, and vomiting. Other signs and symptoms include lack of energy (lethargy), low blood glucose (hypoglycemia), weak muscle tone (hypotonia), delayed development of milestones, liver problems, and abnormalities in the light-sensitive tissue at the back of the eye (retina)."
Organic Acidemias 225,metabolic,indu,6057,1,no,autosomal recessive  ,6120,Nervous system,BTD,GCAAACGCGAAATCGGCAGCACGCCACCTCTGGTACTGCACCTCTGACGGACAGGAGGGCAACCAACTGCCTTAAACAACGGGAAGGAAGAGGCGGTCTAAATTCGTC,"Organic Acidemia, also known as organic aciduria, is related to isovaleric acidemia and methylmalonic aciduria due to methylmalonyl-coa mutase deficiency. An important gene associated with Organic Acidemia is BTD (Biotinidase), and among its related pathways/superpathways are Infectious disease and Metabolism. The drugs Carbamide peroxide and Hydroxocobalamin have been mentioned in the context of this disorder. "
Tyrosinemia 227,metabolic,indu,58,1,no,autosomal recessive  ,112,Metabolism/homeostasis,HPD,CCTGGAACCTTCCAGGGCTGGGCTCAGCTCCCCACCCCATCCCCCAGGTAGGCCAGGAGGCCTGGGCGGGACCTGCTTGGGGTTAAATACTCCGGCCCAGCACTCCCC,"Tyrosinemia is a genetic disorder characterized by problems breaking down the amino acid tyrosine, which is a building block of most proteins. If the condition is untreated, tyrosine and its byproducts build up in tissues and organs, which can lead to serious health problems. There are three types of tyrosinemia, distinguished by their symptoms and genetic cause. Tyrosinemia type I is the most severe form of this disorder and usually begins in the first few months of life. Affected infants do not gain weight and grow at the expected rate (failure to thrive) because eating high-protein foods leads to diarrhea and vomiting. Affected infants may also have yellowing of the skin and whites of the eyes (jaundice), a cabbage-like odor, and an increased tendency to bleed (particularly nosebleeds)."
Methylmalonic Acidemia 163,metaboilc,indu,419,5,yes,autosomal recessive  ,499,Nervous system,MMUT,CCCTTCTGAGAGCCGCGCTTAGAGTAATTCGCGCCCAAACATTCGTAAACAGAGGAGACCCGGAAGTGGGTGGGAAGAAAGCGGAAACGGGCATCTAACCCTACCCCT,"Methylmalonic acidemia is a group of inherited disorders that prevent the body from breaking down proteins and fats (lipids) properly. The effects of methylmalonic acidemia, which usually appear in early infancy, vary from mild to life-threatening. Affected infants can experience vomiting, dehydration, weak muscle tone (hypotonia), developmental delays, excessive tiredness (lethargy), an enlarged liver (hepatomegaly), and failure to gain weight and grow at the expected rate (failure to thrive). Long-term complications can include feeding problems, intellectual disabilities, movement problems, chronic kidney disease, and inflammation of the pancreas (pancreatitis)."
Urea Cycle Disorder 165,metaboilc,indu,367,1,no,autosomal recessive  ,633,Nervous system,SLC25A13,GGTCACGTGTCCCTGTCCAGCCACTGCCCCAGGATCTGAGCCCTCCCCGGCTGCAGGGCAGAGGCCGCTGGATCACGCGCACCCCGGCGGCCAAGGCTGGGCCCAGCC,"Urea Cycle Disorder is related to carbamoyl phosphate synthetase i deficiency, hyperammonemia due to and n-acetylglutamate synthase deficiency. An important gene associated with Urea Cycle Disorder is ASL (Argininosuccinate Lyase), and among its related pathways/superpathways are Metabolism and Regulation of expression of SLITs and ROBOs. The drugs Protective Agents and Phenylacetic acid have been mentioned in the context of this disorder. Affiliated tissues include liver and brain, and related phenotypes are homeostasis/metabolism and growth/size/body region."
Adrenoleukodystrophy 218,metaboilc,indu,112,1,yes,X linked recessive,167,Nervous system,ABCD1,CCGGACTCCGCCCCTCGCCCCTCCTCCGCCTCCTCCCCTTCCCCCGACTCGCCCCTGGGGAAGAGTGGGTGGGGATTCTGGGCCGGTGGAGGAGTCACTGTCGCTTCA,"X-linked adrenoleukodystrophy is a genetic disorder that mainly affects the nervous system and the adrenal glands, which are located on top of each kidney. In this disorder, the fatty covering (myelin) that insulates nerves in the brain and spinal cord tends to deteriorate (a condition called demyelination). The loss of myelin reduces the ability of the nerves to relay information to the brain. In addition, damage to the outer layer of the adrenal glands (adrenal cortex) causes a shortage of certain hormones (adrenocortical insufficiency). Adrenocortical insufficiency may cause weakness, weight loss, skin changes, vomiting, and coma. There are four distinct types of X-linked adrenoleukodystrophy: a childhood cerebral form, an adrenomyeloneuropathy type, an adrenal insufficiency only form, and a type called asymptomatic. "
no phenotypes,reproductive,vasu,,,,,,,PAX8,TCCCGCACCCCCCTGCACCCAGCCAGCCAATCCGCGGCCTACGAGCCTCGCCAGACCCATCTCCCAGGGCCTCAGCGGGATAAAACCGGTCGGTGATGCCGGGTGGAT,
Gm1 Gangliosidosis,lyosomal,rudra,17,2,yes,autosomal recessive  ,58,Skeletal system,GLB1,CGCGGTCCCGCAGGGCGGGGAGCCTGAGCCCCGAAGTGCCCCCCAGCAGGCTCGCGGCCGGCGGAACGCAGGCAGTGGACCGGCCTTCCCGTCGGGGGCGGGCCGGGC,
Hurler Syndrome,lyosomal,rudra,90,2,yes,autosomal recessive  ,85,Skeletal system,IDUA,GGGGCTCCAAGCCCTGCCGTGCTCCCGGCTCCCCGAGGCTCCCCGAGGCCACCCAACCCCTCCCACCCGGCCATCGCCCCCTCACCAAGGCCCCGCCCCGCGGCGGCG,
Mucopolysaccharidosis Type 2,lyosomal,rudra,263,1,yes,X-linked recessive  ,95,Head or neck,IDS,CAACTAAGGGGTAGGGATTGGGAGAGATGCACAGGCAAGCATTATCTCTGTATGCCTTGGCAATTTAAATTGCAGTCACTCTCATTTTTATTTTTTTTCAATTTGCAG,
Mucopolysaccharidosis Type 4A,lyosomal,rudra,36,2,yes,autosomal recessive  ,71,Skeletal system,GALNS,CGCACACAGCTGGCTCAGGCCCCGCCCCACTGGTCACGAGGCAGTCCAGGCCCCGCCTCCCGTCCCTCCGCGGACTCTGGCCCCGCCCCGCGAGTCACGTGGCCGTCC,
gaucher,lyosomal,rudra,59,3,yes,autosomal recessive  ,16,Head or neck,CHIT1,TGTCCCCTTCACCCTGTTCTCCCGGGTCAAAGGCCAACGCTGGACCATTTCTATATCCTGGGCCTGCTCAGGGAGGGCTCTGGGCTAAAGGAATCGCGATGCTGGGCA,
Batten Disease,lyosomal,rudra,27,1,yes,autosomal recessive  ,89,Nervous system,CLN3,TCCAGCCCCTCCCTTTTTCACGCTCCGAAGCCGAGAAGGCCCAAAGCGAAGACAGAGAGGACCCGGAAGTAGGGAAAACCTCTGAGCACGTGATGGGGGAACACGCGG,
Hunter Syndrome,lyosomal,rudra,263,1,yes,X-linked recessive  ,95,Head or neck,IDS,CAACTAAGGGGTAGGGATTGGGAGAGATGCACAGGCAAGCATTATCTCTGTATGCCTTGGCAATTTAAATTGCAGTCACTCTCATTTTTATTTTTTTTCAATTTGCAG,
Multiple Sulfatase Deficiency,lyosomal,rudra,49,2,yes,autosomal recessive  ,42,Nervous system,SUMF1,ACAGGCAAGCAGCAGCGCCAAAGAAGTACCTGAAGAAAGGTGAAGAGCAACTCTCCTGGTCACTTCGTAAGTCAGCTCAAAATTCTGCCCCTTTAAGGAGGGCTCAGC,
Niemann-Pick Type C,lyosomal,rudra,135,6,yes,autosomal recessive  ,271,Nervous system,NPC1,CTGGGGCAGGAGAATCACTTGAACCTGGGAGAAATCCTTGTAAGGAAGTGTTTTTGTTCAATTACAGGTTGGTAAAAGTGGTTTCTAACACAGTATCTCTTCTTTTAG,
Pompe,lyosomal,rudra,108,5,yes,autosomal recessive  ,311,Nervous system,GAA,GGGGGGCGTAGCGCGGACGCGCACCCTTGCCTCGGGCGCCTGCGCGGGAGGCCGCGTCACGTGACCCACCGCGGCCCCGCCCCGCGACGAGCTCCCGCCGGTCACGTG,
Sanfilippo Syndrome,lyosomal,rudra,214,4,yes,autosomal recessive  ,264,Nervous system,HGSNAT,CCCGCCCGCGGCTCCCGGGCGCCTCCGCCTCCCGCGGTGACTCAGGCGGCGGTGACGGCAGCGGAGGGGGCGATGACGGGCGCGCGGGCGTCCGCGGCGGAGCAGCGC,
Ddost-Cdg,lyosomal,rudra,26,1,yes,autosomal recessive  ,3,Nervous system,DDOST,GCGCTCGGCCTCGTTGATTGGCCGCGGCTGCAGAGCTGTCTCTCTAGGATTGAGCCTTTTCTTTAGGGGGACGGGGCCTTGATTCACTCCCACCAATAGGGTTCAAGG,
Fabry,lyosomal,rudra,78,2,yes,X-linked recessive  ,233,Cardiovascular system,GLA,AATAGGGCGGGTCAATATCAAGAAAGGAAGAGGGTGATTGGTTAGCGGAACGTCTTACGTGACTGATTATTGGTCTACCTCTGGGGATAACCGTCCCAGTTGCCAGAG,
Late Onset Tay-Sachs,lyosomal,rudra,31,3,yes,autosomal recessive  ,168,Nervous system,HEXA,CTTCTCGAGTCGGGTGAGCTGTCTAGTTCCATCACGGCCGGCACGGCCGCAGGGGTGGCCGGTTATTTACTGCTCTACTGGGCCCGTGAACAGTCTGGCGAGCCGAGC,
Mucolipidosis,lyosomal,rudra,22,1,yes,autosomal recessive  ,44,Skeletal system,GNPTG,CTCCTGCGGCCCATGGCGCGGACCTGGGGTGCCGGGGACTCCCCACCCCACGGCCGCGCCCCTCGGCCTCCCAATGGGCTGTGCGGCTGCCAGCGCTTGCGCCGGACG,
Mucopolysaccharidosis Type 1,lyosomal,rudra,214,2,yes,xlinked,197,Skeletal system,IDUA,GGGGCTCCAAGCCCTGCCGTGCTCCCGGCTCCCCGAGGCTCCCCGAGGCCACCCAACCCCTCCCACCCGGCCATCGCCCCCTCACCAAGGCCCCGCCCCGCGGCGGCG,
Polycythemia Vera,cns expansion,veda,39,5,yes,autosomal dominant  ,4,Blood and blood-forming tissues,JAK2,TGCGTGGCCCGCGCCTGCCGGTCCCGCGACCAGCACCGAGCGGCGCACGCGCACTGCAGGACGCGCGTCCGGCTCTCCCCCAGCCTCTATCCGGCCCGGTCTCCTGCC,
Mesenchymal Chondrosarcoma,cns expansion,veda,1,1,no,sporadic,2,Skeletal system,NCOA2,TTTATTTGGCTGTGGTGCCTTATGGCAGTTAGGTCAGTGATTGCAAATGGGCTTGTGGTGTCTACTCTTAGAGTAGACTGGATAAACTCTTCTGTTTGTCAACTACAG,
Cutaneous T-Cell Lymphoma,cns expansion,veda,78,1,no,sporadic,8,Integument,TNFRSF8,CAGCTAAGGGAGGCGTCTCCTAGTGTGCCTTTTCCTGAGTCATCTCTGCACGTGTTTGCCCCCTTTTTTCTTCGCTGCTTGTAGCTAAGTGTTCCTGGAACCAATTTG,
Synovial Sarcoma,cns expansion,veda,1,3,yes,sporadic,1,Nervous system,SSX2,TCTATCAGTCCCGGCTCCAGGGACGGAACCTTCTCAAAGTGGGGGTGGAGACTCTAATTTTCCCGCCTAAAGCATCCCCTGGGATTGGCTACTTTAAGTTCAGAGTAC,
Thymoma,cns expansion,veda,33,1,yes,sporadic,10,Immune system,KIT,GAAGAAGCGAGACCCGGGCGGGCGCGAGGGAGGGGAGGCGAGGAGGGGCGTGGCCGGCGCGCAGAGGGAGGGCGCTGGGAGGAGGGGCTGCTGCTCGCCGCTCGCGGC,
Cns Lymphoma,cns expansion,veda,0,1,no,somatic mutation,7,Nervous system,MYD88,TTCCTACAACCCCCGAAGGAGGGTCGTCCTCACTCCGCCGCCAACCTACTAGCACCATCACCAGACCCTCGAGGGCGGTGCCGTGGACCTCTCCAGATCTCAAAAGGC,
Multiple Myeloma,cns expansion,veda,29,12,yes,sporadic,366,Blood and blood-forming tissues,LIG4,CCTGAGGGGCGTCAGGTGGGGGGGTCTGGGAGGCGTCAGGCGGGGGTCGGTCTATGGGGGCAGCAAGCAGGGTGTTTGTGCAGCGGCAGGTGATGGGAGTTGCCGAGT,
Pheochromocytoma,cns expansion,veda,16,8,yes,autosomal dominant  ,210,Cardiovascular system,TMEM127,GGGACCGCCTCGAACTACCAGTCCCGTGAGGCCCTGCGCAGAGCCGGCGGCGCGCCCAGGCTGTGACGCGCGCGGGGGACGGGGCGGGGAGCCGGAGGAGGCGGAGGC,
Desmoid Tumor,cns neoplasms,veda,22,2,yes,autosomal dominant  ,14,Digestive system,APC,GAAGCAGTGCCCGGCAAGCGGAGCGCAGCACCCATTGCGCCTGCGCATAACAGGCTCTAGTCTCCGGGCTGTGGGAAGCCAGCAACACCTCTCACGCATGCGCATTGT,
Paraganglioma,cns neoplasms,veda,138,3,yes,sporadic,318,Nervous system,SDHB,TCAGACTCCTCCCCTTTCTGAGAAGGTCACGGGGGAAGCCAAATGGGCATGCGCCGCTACTGCGCTATTGCGCACGCTCGCTGTGCTTGCCCCGCCTTCCCTCCGCCC,
Pemphigus Vulgaris,skin,aditya,12,1,no,autosomal dominant  ,11,Immune system,DSG3,CTAAGTTTTTACCTGGGAGCAAAGGTGATGCAAGCGTTTCTGGTGAGACCTACCCTTGGTTTAGGGTGGGGAGGGACCGCATAACAGACCATCTGTAGACTCCTTCGG,
Pityriasis Rubra Pilaris,skin,aditya,20,1,yes,autosomal dominant  ,3,Immune system,CARD14,TTCTTACGGCAATGTCTAGCTGTGGGACTGCACTGGTGCTTCGATGGCTCATAGAAGCCCCATATAAGGCACTGCTCCTGTGGGATGTGCCTGTCAAACCTGCTTGTC,
Psoriatic Arthritis,skin,aditya,29,2,yes,sporadic,57,Skeletal system,LTA,ACCTCCTCTCTGAATTGACTGTCCCTTCTTTGGAACTCTAGGCCTGACCCCACTCCCTGGCCCTCCCAGCCCACGATTCCCCTGACCCGACTCCCTTTCCCAGAACTC,
Common Variable Immune Deficiency,immuno,dishi,214,14,yes,autosomal dominant  ,151,Immune system,TNFRSF13B,GCACAGGCATGGGGGCGGGAGTGGGTGTGGCTGATTTACATCCAACAGGTTGAGGGGAAAACCCAGGAAGTGCAGCCCAAGCACTAATCAAATCTAAGACTAGTAATA,
Pulmonary Sarcoidosis,immuno,dishi,56,1,no,sporadic,11,Skeletal system,TNF,CTCATGGGTTTCTCCACCAAGGAAGTTTTCCGCTGGTTGAATGATTCTTTCCCCGCCCTCCTCTCGCCCCAGGGACATATAAAGGCAGTTGTTGGCACACCCAGCCAG,
Sarcoidosis,immuno,dishi,131,2,yes,sporadic,56,Skeletal system,HLA-DRB1,ATACAGCATCTCTGACCAGCAACTGATGATGCTATTGAACTCAGATGCTGATTGGTTCTCCAACACGAGATTACCCAACCCAGGAGCAAGGAAATCAGTAACTTCCTC,
Severe Combined Immunodeficiency Disorder,immuno,dishi,539,7,yes,X linked recessive,420,Immune system,ADA,GGTCCAGAATTCCAGGAAATGCGCGATCCAGGCCGGCGGGCGGGGCGGGGGCTCCGGCGAGAGGGCGGGCCCCGGGAACGGCGGCGGGCGGGGCGGGAGGCGGGGCCC,
Hereditary Angioedema,immuno,dishi,69,4,yes,autosomal dominant  ,68,Metabolism/homeostasis,SERPING1,GAACTGCACCCAAGCTTCCCCGTTCACCCCACCTACCAGGGGATTTGGGCTAAATTCCTGGCCTGGCCCACAAAGAAGACCAAGCGGTCAGTCCCATTCCGTCCCATC,
Ryr1 Gene Mutation,immuno,dishi,104,1,yes,autosomal dominant  ,145,Musculature,RYR1,CAGGGCTCCGGCGAAGGGGAGTGGCCGGGGAGTCCTGGTCCAATGGGGCCCGGGGGCGGGGACTTCCTCCCATCTCTGTCCAGCATGCGTGTACTCCTCGCAGTTCCA,
Systemic Juvenile Idiopathic Arthritis,msk,bana,108,4,yes,sporadic,118,Skeletal system,LACC1,GCCCGGCCTCACGCGACCCACCATTCCCGCCGCCCCCTCACGGTGCCCGCCGTTCCCGCCGCCCGGCTTTCTAACCGGGCCCCTAGTTCCCCGCCCCGTGCCCTCTGG,
Thrombotic Thrombocytopenia Purpura,msk,bana,33,1,yes,autosomal recessive  ,38,Metabolism/homeostasis,ADAMTS13,GGCTCCATCACAGGGTTGAAGTAATCACCAGGCACTGAGCCAAGAGTGCCAACCTCACAATCTCCTTATGATGCCACCATGACTACCACAAGGCACAGAGGACGTCAG,
Polyostotic Fibrous Dysplasia,MSK,bana,59,1,no,sporadic,12,Skeletal system,GNAS,CTCGGCGCCACCACGCAGCTCGCGGGGAGGTGGCCCCCACCTCCTTACTGCACATGCCCGGCAGAAGTCCGGGCGCGCAACTTCGCAGAACCTCACTGCCCGTCCCTC,
Anca Vasculitis,msk,bana,174,1,no,autosomal dominant  ,42,Immune system,PRTN3,GTCCGTTCTGACTCCCAGGCTCCCAAGGCAAAAGGAGGAAGTGGGGACCCAGCCTGGGCATTGGGCAACTCAACGGCCTCTGGCATTGGGCTATAAGAGGAGCTTGAC,
Ankylosing Spondylitis,msk,bana,0,1,no,autosomal dominant  ,371,immune system,HLA-B,CCAACTTGTGTCGGGTCCTTCTTCCAGGATACTCGTGACGCGTCCCCACTTCCCACTCCCATTGGGTATTGGATATCTAGAGAAGCCAATCAGCGTCGCCGCGGTCCC,
Sjogren's,msk,bana,78,6,no,autosomal recessive  ,57,Immune system,TRIM21,TCTCAGCCGCATTTCTCCACACACCCTTTCAAGGCTCTGCTCCTCCCACTGCTCCTCCCTCACTCCTCCCACGGCTCCTCCTCCTCCCTCCCCTTTCCTCTCAGACTT,
Hypochondroplasia,msk connective,bana,28,1,yes,autosomal dominant  ,26,Skeletal system,FGFR3,CGGGCGGGGACCGGGCGGGAGCGGGGCGGGGCCGGGGCGGGGCGCGGACCGTCCCCCACTGGCTGCGGCGCGCGGGGCAGCCCAGGCTCAGTGCGCGGTGGCGGCGGC,
Short Rib Polydactyly Syndrome Type 2,msk connective,bana,40,1,yes,autosomal recessive  ,34,Skeletal system,IFT80,CTTTCGAACGAGCCCAGCAATAGTTCCCATTGGCCGATGCCTTGCAGTTGAATGTTGCCTGCAGACTGCGCCTGCGCTGCGAGGCTCCGCGAGGCCCCGCCCGGTCTG,
Myositis,msk connective,bana,211,1,no,autosomal dominant  ,187,Musculature,NARS1,AAGGAAGGGTGCAAAAGTGACACTGTGCCAGGGTCTCCAGGGCCGCGGAGCTCCGGGACAGGCAGCGCCTTCCGAGCTGCACAAACGCGTGGGGCGGGGCGTCTCTGG,
Systemic Scleroderma,msk connective,bana,112,1,no,sporadic,149,Integument,TSIX,TAGCTTTGCTGTATTCCAATAAAACTTTATTAATGGACATTGAAATTTGAATTTAATATATTTTTTGTTTGTCATGAAATATTCTATAATTTTTTTCTTCCAACCATT,
Vasculitis,msk connective,bana,783,1,no,sporadic,242,Immune system,PRTN3,GTCCGTTCTGACTCCCAGGCTCCCAAGGCAAAAGGAGGAAGTGGGGACCCAGCCTGGGCATTGGGCAACTCAACGGCCTCTGGCATTGGGCTATAAGAGGAGCTTGAC,
Ehlers Danlos Syndrome,msk connective,bana,90,8,yes,autosomal recessive  ,25,Skeletal system,COL3A1,CTTTTACTGCTGAGGGGATGGGTGCGGCTCTCATATTTCAGAAAGGGGCTGGAAAGTGAGGGAAGCCAAACTTTTTCCTATTTAAGGCCAAAGCAAAGGAATCTCAGT,
Hypermobile Ehlers-Danlos Syndrome,msk connective,bana,60,9,yes,autosomal dominant  ,1,Skeletal system,COL1A1,GCCAGGCAGCTCTGATTGGCTGGGGCACGGGCGGCCGGCTCCCCCTCTCCGAGGGGCAGGGTTCCTCCCTGCTCTCCATCAGGACAGTATAAAAGGGGCCCGGGCCAG,
Klippel Feil Syndrome,msk connective,bana,5,1,no,autosomal dominant  ,1,Skeletal system,MYO18B,CCTGGAGCTCACAAGCTAATTTTAGAAATGACTGGTCGACTCAGCTGCTGCTATCACATTGGCCCAGAAGGAGGGTGGGGGGAGGACGGGTCGGGGAGGGGCAGTAAG,
Mccune-Albright Syndrome,msk connective,bana,59,2,yes,Somatic mosaicism,12,Skeletal system,GNAS,CTCGGCGCCACCACGCAGCTCGCGGGGAGGTGGCCCCCACCTCCTTACTGCACATGCCCGGCAGAAGTCCGGGCGCGCAACTTCGCAGAACCTCACTGCCCGTCCCTC,
Osteogenesis Imperfecta,msk connective,bana,12,10,yes,autosomal recessive  ,2,Skeletal system,COL1A2,CCTACAAGTGGCCTACAGGGCACAGGTGAGGCGGGACTGGACAGCTCCTGCTTTGATCGCCGGAGATCTGCAAATTCTGCCCATGTCGGGGCTGCAGAGCACTCCGAC,
Bechet Disease,msk connective,bana,80,18,yes,autosomal recessive  ,35,Immune system,MEFV,CCTTAGTCTCAGTTCCCACCAAGACACAGAGCATTTCCTGTGCCTTTTCCGCTATTTCACAACCTGCCTTTTCTTGCTCACCAAGGACAGAGGCTTCTTTTCCTACCA,
Chronic Recurrent Multifocal Osteomyelitis,msk connective,bana,27,1,no,autosomal recessive  ,2,Skeletal system,LPIN2,CAAAGTCGGTTTTGAAATACATTTTGAAATATTTACGAATTATTTAGTGGCCCATACTGGTTTATGTTTTAACGGTCTGGTGTTGATCGTTCTTAGTGGCTTCAGATT,
Fibrodysplasia Ossificans Progressiva,msk connective,bana,33,2,yes,autosomal dominant  ,19,Skeletal system,ACVR1,ACCAATAAGCAACTTGTCACTATGGGTTGTTTTTTTTTCCCCCACCTCTTGATAGCAAGGGTCTATCGGAAGTTTAAAGCAATGCAGCGGGAAGTACCTTGCCTTTTT,
Granulomatosis With Polyangiitis,msk connective,bana,137,5,yes,sporadic,42,Immune system,PRTN3,GTCCGTTCTGACTCCCAGGCTCCCAAGGCAAAAGGAGGAAGTGGGGACCCAGCCTGGGCATTGGGCAACTCAACGGCCTCTGGCATTGGGCTATAAGAGGAGCTTGAC,
Juvenile Dermatomyositis,msk connective,bana,46,1,no,autosomal dominant  ,5,Cardiovascular system,CCR6,CCCCAAGGCTCGGTGTCCAGCGTCAACCCCGAGGTCTCTATGCCCCGCCTCCCGACGCCAGGGGGCAGGGCCAGCGCGCTGCGCGTCGGGGCGGGGCTTTGGCTGCGT,
Progressive Familial Intrahepatic Cholestasis,msk connective,bana,11,4,yes,autosomal recessive  ,10,Digestive system,ATP8B1,CCACTAGCGAGCCGCGAGAGCCGGAGGTGCCGCCGCCAACTAGACACGCTTCCCCGGGCCCCCGGCCAGCCCCCGTGCGCCATGCAGCGCTAGCGCGGCGGCCAGGGC,
Takayasu Arteritis,msk connective,bana,39,3,yes,autosomal recessive  ,61,Cardiovascular system,HLA-B,CCAACTTGTGTCGGGTCCTTCTTCCAGGATACTCGTGACGCGTCCCCACTTCCCACTCCCATTGGGTATTGGATATCTAGAGAAGCCAATCAGCGTCGCCGCGGTCCC,
Idiopathic Pulmonary Fibrosis,msk connective,bana,87,1,no,autosomal dominant  ,145,Respiratory system,PARN,CCTTGGGGACTTCGATAGCCACGCCCCTCCCCTGTCCCTATAAGGAGGGAAAGGAGCCCAGCCTTGGCCCCGCCCCCGCCGCCGCGCAGGCGCTGACGCAAGCGCAGC,
Focal Segmental Glomerulosclerosis (FSGS),msk connective,bana,84,10,yes,sporadic,64,Genitourinary system,NPHS1,AAAAGAAAAAAAAAAGAAAAAAGAAAAAAAAGTTTTTTTAAAGAGACAGAGAAAGAGACTCAGAGATTGAGACTGAGAGCAAGACAGAGAGAGATACTCACAGGGAAG,
15Q11.2 Microdeletion,congenital and chromosomal,bhrama,19,3,yes,autosomal dominant  ,3,Nervous system,NIPA1,GCCCCCGCCCCTCTTCCTGCTCCTCCCCCACCCGTCCCCCTCCCCTCCCCCGCCCGCGCCTCCCGGTCACCCCCCATCCCGCCCCGCGGGGCGCGGCGCGCAGGCGCA,
22Q11 Chromosome Duplication Syndrome,congenital and chromosomal,bhrama,47,1,yes,autosomal dominant  ,17,Head or neck,TBX1,CGAGCCCTGAGGAATCAGACCCTGCGACCCCTAGCCGCGCCTCACCTTCCTGATCCACGCAAGGGAGCTCCCAGTCAGGCCTCCTATCGCGCGGGTGTGGAGGTGCGG,
22Q13 PhelanMcdermid Syndrome,congenital and chromosomal,bhrama,91,1,yes,autosomal dominant  ,41,Nervous system,SHANK3,CGACGGGGCTCCGGCGGGGGGGAAGGGGGGGCCGGGGCGCCGCGCGCGGAGTCCCCGGGCGCTCCGTTCCCCGGCGCGAGCGGCCCCGGCCCGGGCCCCGGCGCGGGG,
2Q37 Deletion Syndrome,congenital and chromosomal,bhrama,71,1,yes,somatic mutation,5,Skeletal system,HDAC4,ACCCCCCCCCCGCCCCGTGAAGGTGGCCAGTGTGTTGGGTGGGGGCTCTGGGGCCCAGGGACAGCAAAGGGCGGCAGTGACCGGCTCTCCTGCTTGTTTTTCCCACAG,
7Q11.23 Duplication Syndrome,congenital and chromosomal,bhrama,102,1,yes,autosomal dominant  ,2,Head or neck,GTF2I,TACAACTCCCGCTGGGCGGCGCTGCGGATGCGCAGGCGCAACGCGCCTTCGAGGAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAGAAAAAAGAAAAAAAAAAGGAGG,
Angelman Syndrome,congenital and chromosomal,bhrama,184,6,yes,autosomal dominant  ,184,Nervous system,UBE3A,CTTAATATGCATTTTAAAGTATGCCTTTTATGTGGTGAACGTTTTAACTAAACATTTCTCTAGAAGTTTTTATAACATTAATAAAACTAGTATACTTTTCTCTCCTAG,
Fragile X Syndrome,congenital and chromosomal,bhrama,37,1,yes,X-linked dominant  ,40,Nervous system,FMR1,CCGCGGGGGGAGGGAACAGCGTTGATCACGTGACGTGGTTTCAGTGTTTACACCCGCAGCGGGCCGGGGGTTCGGCCTCAGTCAGGCGCTCAGCTCCGTTTCGGTTTC,
Jacobsen Syndrome,congenital and chromosomal,bhrama,103,2,yes,sporadic,5,Skeletal system,FLI1,CTGGCCTGAAGCCCGGGGACGGGACTGAGGCGTAGGGAGAGTGCTCAACACCCAACCACTCGGACCCTCCCTCGCCGGACTAGGCGGATCTGAGCTTCCCAAACCCCT,
Phelan-Mcdermid Syndrome,congenital and chromosomal,bhrama,91,1,yes,autosomal dominant  ,41,Nervous system,SHANK3,CGACGGGGCTCCGGCGGGGGGGAAGGGGGGGCCGGGGCGCCGCGCGCGGAGTCCCCGGGCGCTCCGTTCCCCGGCGCGAGCGGCCCCGGCCCGGGCCCCGGCGCGGGG,
Williams Syndrome,congenital and chromosomal,bhrama,234,21,yes,autosomal dominant  ,11,Skeletal system,ELN,GCCCGGGCCTGGGAGGCTTGTGAGCCGGGCCTTTCGTAATTGTCCCCTCCCCGCGGCCCCCTCCCCCAGGCCTCCCCCCTCTCCCGCCCTCCCGCCCGCCCTCTCTCC,
Adnp Syndrome,congenital and chromosomal,bhrama,106,1,yes,autosomal dominant  ,36,Head or neck,ADNP,CCCACACCCTCCGTCTCCTCCCTCCGCCCCTCCTTTGTCTGCACCGCTCGACGACGCCGCCGCCGCCCGCCGCTCTGCTGCGCCCGCCGCGCCCCCCGGCAGCACCCG,
Autosomal Recessive Alport Syndrome,congenital and chromosomal,bhrama,13,3,yes,autosomal recessive  ,216,Genitourinary system,COL4A4,TTGAAGTTACCCTTTAGAAAATATTTCCATAACGATAAAAAATGAAAGTAATTATTTTCAACATTATAATGCATGCTGTGTTTTAAGTGATATATTTATATCTAACAG,
Blue Rubber Bleb Nevus Syndrome,congenital and chromosomal,bhrama,25,2,yes,autosomal dominant  ,1,Cardiovascular system,GLMN,CCGGCCTTGCGGCCGGCAGAAGACGGCCCAGCGAAGTCCGCCATGGGGGAGAGTAGTCTGCCGGACGGGGACACGCTCCGGCGTCTCGCCCCGAGGCCCCGCCTCCCT,
Choanal Atresia,congenital and chromosomal,bhrama,16,1,no,autosomal recessive  ,2,Respiratory system,CHD7,CGCGGGCGCGGCGCGGCCCGGAGGGAGCTGGCGGCGGGCGCGCGCGGCCCCGCGGCTTCGGGTGCGCGCGGCGTGCCGGACGCGCGCAGGCGCTGGCGTGCTGGGGCC,
Cloves Syndrome,congenital and chromosomal,bhrama,16,2,yes,sporadic,7,Skeletal system,PIK3CA,GGGACTGGGGCTGGGGCCGCCGGCGAGGCAGGGCTCGGGCCCGGCCGGGCAGCTCCGGAGCGGCGGGGGAGAGGGGCCGGGAGGCGGGGGCCGTGCCGCCCGCTCTCC,
Constitutional Mismatch Repair Deficiency (Cmmrd),congenital and chromosomal,bhrama,15,4,yes,autosomal recessive  ,51,Nervous system,MLH1,ATTCCCCGAGCTCCTAAAAACGAACCAATAGGAAGAGCGGACAGCGATCTCTAACGCGCAAGCGCATATCCTTCTAGGTAGCGGGCAGTAGCCGCTTCAGGGAGGGAC,
Dandy Walker Syndrome,congenital and chromosomal,bhrama,19,3,yes,sporadic,22,Nervous system,KMT2D,CCAGGATTCTGGGAAAAATGCTTCTTGGGAAGACTTAGTAGGCATATAGATCTCTTTCTTGGCACCAACAGGTCTCCCCGAGAGGGCCCTGCCCAGTCGGAGAGAGGG,
Floating Harbor Syndrome,congenital and chromosomal,bhrama,69,1,yes,autosomal dominant  ,7,Skeletal system,SRCAP,CGAACGCCCCACAGTTCCCCCTCCCATGACGGCTGACTGCGCGCGCATCTTTCCGCCACCGCCTCCCCCCCACCTTCCCGGGGTGCTGCGCGCGCACCCTCAGCCGGG,
Hereditary Lymphedema,congenital and chromosomal,bhrama,1481,2,yes,autosomal dominant  ,915,Head or neck,FLT4,TGCACCGGACGCCCCGCGGCGGGCTGGGAGGGACGGGGGGAGGGGGGCGCGGGGAGCGGCCTGAATCCCGGGCCCGCCTCCGGCCCCCGCCCCGCCCCGCCCCGCCCC,
Hypoplastic Left Heart Syndrome,congenital and chromosomal,bhrama,3,4,yes,autosomal dominant  ,1,Cardiovascular system,TBX20,CCCCGGCGGCGGAATCAGGAAGCGGTGACGTGAGACGGCGCTGACTGGCTGCGGGCCTCCGGGATCGCCGCCGCCAGCAAATTAAGGCGCAGGGCAGCGAGCGCCAGG,
Isolated Congenital Asplenia,congenital and chromosomal,bhrama,3,2,yes,autosomal dominant  ,7,Blood and blood-forming tissues,RPSA,AAGAAAAAGCCCAGTCCCGGCAGCGTTCTTCTCCGGCTCCGCCCTTCTTCCGCTCGACTTTCTTTGCCATTGGCTGACAACGGAGTACATAAGGACGTCATTTCCTGC,
Li Fraumeni Syndrome,congenital and chromosomal,bhrama,5,5,yes,autosomal dominant  ,16,Nervous system,TP53,CTCAGACACTGGCATGGTGTTGGGGGAGGGGGTTCCTTCTCTGCAGGCCCAGGTGACCCAGGGTTGGAAGTGTCTCATGCTGGATCCCCACTTTTCCTCTTGCAGCAG,
Loeys-Dietz Syndrome,congenital and chromosomal,bhrama,72,3,yes,autosomal dominant  ,20,Skeletal system,TGFBR2,GGTGTGGGAGGGCGGTGAGGGGCAGCTGAAAGTCGGCCAAAGCTCTCGGAGGGGCTGGTCTAGGAAACATGATTGGCAGCTACGAGAGAGCTAGGGGCTGGACGTCGA,
Marfan Syndrome,congenital and chromosomal,bhrama,89,4,yes,autosomal dominant  ,1544,Skeletal system,FBN1,CAGTAAAAGTAAATTACGGTTTTTGAACAGTTCCTGAAGTGGGTTTGAATTTTCAACCCCAGTAGAAAGATTCTGCCTGATGCTTTTGTGTTTGTATATGGTAAATAG,
Noonan Syndrome,congenital and chromosomal,bhrama,20,21,yes,autosomal recessive  ,14,Skeletal system,PTPN11,AGCTAATGAGTGGAGCGGCGATTTGTGGAACGAAATGAATGAAATCGATGTGGCAGCGGGCCCGGACGGGTCGGTGGCGTAGACGCGGAGCGCGCAGCTCACACCTGG,
Prader-Willi Syndrome,congenital and chromosomal,bhrama,613,7,yes,autosomal dominant  ,38,Nervous system,MAGEL2,GTGGTGGTCGGGGGCGGGGAAGGGGCGGGATTGAGCCCCCTTCCCCCCTCCTCCTTACTGCGGAAAGCTGCGGAGCGAGCAGCACTCACTTCCTATTCAGCATTCAGC,
Primary Ciliary Dyskinesia,congenital and chromosomal,bhrama,13,54,yes,autosomal recessive  ,5,Respiratory system,DNAAF5,CACGTGCGCACCGGCGGGGAGGAAGTAGCCCGGCGCCCCGCCCGCAGCGCGGACCGGAAGTGCTGCCGTAATCTGCGCTGAGAGTCGCGAAAGCGCTGTTCCCCTTAG,
Snyder-Robinson Syndrome,congenital and chromosomal,bhrama,80,1,yes,X-linked recessive  ,13,Head or neck,SMS,CTGCGCTGTTTAAACCTAAGGTGACCTAACGGATGGCGGGAGCGGCCGCGCGAGCCTTGGAGCAGGGCGCGGCCATTGGTGACGCACGCCGGGGAGCACGGCGCCCAC,
Sturge-Weber Syndrome,congenital and chromosomal,bhrama,41,1,yes,sporadic,1,Skeletal system,GNAQ,ATTAGCCGGGCGTTGTGGCAGACGCCTGTAGTCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATGGCATGAACCCGGGAGGCGGAGCTTGCAGTGAGCCGAGATTTGC,
Von Hippel Lindau Disease,congenital and chromosomal,bhrama,47,3,yes,autosomal dominant  ,252,Nervous system,VHL,CAGCCCGGGCGACAGAGTGAGACCCTGTCTCAAAAAAAAAAAAAACACCAAACCTTAGAGGGGCGAAAAAAAATTTTATAGTGGAAATACAGTAACGAGTTGGCCTAG,
X-Linked Hypohidrotic Ectodermal Dysplasias,congenital and chromosomal,bhrama,49,2,yes,X-linked recessive  ,118,Integument,EDA,CCGGCTGGAACGGCACGGGGCGGGGCGCCAAGGCTTGGCGGCCCCGTGGTTGGGCGTCCCGGCAGCCGCTTGAGGGATGGGGCGGGGTCGGCCGGGACCTCCTCCTTC,
22Q11.2 Deletion Syndrome,congenital and chromosomal,bhrama,62,13,yes,autosomal dominant  ,5,Skeletal system,TBX1,CGAGCCCTGAGGAATCAGACCCTGCGACCCCTAGCCGCGCCTCACCTTCCTGATCCACGCAAGGGAGCTCCCAGTCAGGCCTCCTATCGCGCGGGTGTGGAGGTGCGG,
Vacterl Syndrome,congenital and chromosomal,bhrama,82,1,yes,sporadic,10,Skeletal system,FANCL,CAGAGCGCCACTTGGCCTGGCCTGCGCTTCACCTTCATTTCCGCCCGCGGAATCCTCCAGGATCTTCCCGCCAAGGCTGGGGTTTCCGCTCCGCGGCGTCCGAGCGCC,
Epidermolysis Bullosa,congenital and chromosomal,bhrama,285,1,yes,autosomal dominant  ,114,Integument,KRT5,AGAGCCTGCCAGGAAGAAAGCGTTTGCACCCCACACCACTGTGCAGGTGTGACCGGTGAGCTCACAGCTGCCCCCCAGGCATGCCCAGCCCACTTAATCATTCACAGC,
Hypohidrotic Ectodermal Dysplasia,congenital and chromosomal,bhrama,196,3,yes,autosomal dominant  ,201,Integument,EDA,CCGGCTGGAACGGCACGGGGCGGGGCGCCAAGGCTTGGCGGCCCCGTGGTTGGGCGTCCCGGCAGCCGCTTGAGGGATGGGGCGGGGTCGGCCGGGACCTCCTCCTTC,
Mayer-Rokitansky-Kuster-Hauser Syndrome,congenital and chromosomal,bhrama,35,1,yes,autosomal dominant  ,3,Genitourinary system,GREB1L,GGGCGGGAGGGGCAGCACCTGAGGAATCCGCCTCCGGCTGCGGCGGCCGCCGCCTCGCTCCGCCCCGGGGAACTGAGCGCGCGGACCGCGCGCCTGCCAGAGAGACGC,
Tuberous Sclerosis Complex,congenital and chromosomal,bhrama,130,3,yes,autosomal dominant  ,681,Nervous system,TSC1,CGGCGGGGCTGCCGAGCGCGGCCGTCTATCCTTCCTTTCGAGAAGGAGGGGAGGTCCGGAGGGGGACTCTTTTTCGTGGCGGAGGCCGCCGTCGGCCTTGGCCCTTTC,
Ddx3X Syndrome,congenital and chromosomal,bhrama,26,1,yes,X-linked recessive  ,53,Nervous system,DDX3X,CCTAGGCAACCGCGCAGGAAGGTGTCCGGCCACCTGCGCGCGCCGCCGGCTCCCCTCCATTTCCCCCCGACTCCCGCCCCGGTCACCATCCTACCCTCCTCCCTCCTC,
Turner Syndrome,congenital and chromosomal,bhrama,39,1,no,X-linked recessive  ,3,Skeletal system,SHOX2,CTTCTCCCCCTCTTCCTCTTCTTCCTCCTCCTCCTCTTCTTACTTCTTTTTCTCCTTCTACTTCTCCTCCTCTTTCTTCTTTCTTCTCCTCTTTTTCTTCTTCTTTCT,
Sticklers Syndrome,congenital and chromosomal,bhrama,168,4,yes,autosomal dominant  ,69,Skeletal system,COL2A1,CCGCCCCACCCATGGGGCTGGGAAGAGGGACACTCTAGTACATTCTAGCAAATGGGGATGGACATGGAGGGGCACTTTCACACAATCCTGGCTGATCTCTCTGTTTCC,
Mastocytosis,congenital and chromosomal,bhrama,216,1,yes,autosomal dominant  ,9,Immune system,KIT,GAAGAAGCGAGACCCGGGCGGGCGCGAGGGAGGGGAGGCGAGGAGGGGCGTGGCCGGCGCGCAGAGGGAGGGCGCTGGGAGGAGGGGCTGCTGCTCGCCGCTCGCGGC,
Aarskog-Scott Syndrome,congenital and chromosomal,bhrama,73,1,yes,X-linked recessive  ,22,Skeletal system,FGD1,GGTCAGGCGCAAATCCCGGGCGAGGGGGCGGGGCCCCGGTAACTGGGTCCCAGTGCCGCTGTGGCTGCGGCTGCCTCTGCGAGGCTCCCGCCTCCCCACCCCCCTTCC,
Alport Syndrome,congenital and chromosomal,bhrama,85,3,yes,autosomal dominant  ,1162,Genitourinary system,COL4A5,CGCAGGTTGCCGGTGCAGTCTAAAACTGTGGCGGAGTGATACTCAAATTCCCTTGTGCTGGTGAGGAGGGGGGCCTTGCACGGGGAAGAGAGGGAGGAAAGTAGATCT,
Aplasia Cutis Congenita,congenital and chromosomal,bhrama,22,4,yes,autosomal dominant  ,1,Skeletal system,BMS1,CAAGCGATAGTCCATCCGTCCTTGGCACGGTGACTGCCGGGAGGCCAGGACCAAATGTGTCTCCTTCCGGCTTTTGCACCACACTAACTAACCGGCGCCAGGCCGCAG,
Heterotaxy Syndrome,congenital and chromosomal,bhrama,134,18,yes,autosomal dominant  ,65,Cardiovascular system,CFAP53,GAAGTCCCGAGTGCAGGCGTCTGCGGCCCCCATGGTGACCAGACCGACTTCCGCCCGACCCGCCCACCTCTACCGGCCCCTAATCCCGCGAGGCGCACCATGGCAACC,
Peters Anomaly,congenital and chromosomal,bhrama,19,7,yes,autosomal dominant  ,58,Skeletal system,B3GLCT,CCAGCCCGGCAGACGCTGGAAGCGCGCACAGGGGTGCTCCCGCTCCCGGCCGCCAGAGGGCGCGGCCGGCGATGGCGCGGCGGAGACGGAGGGAGGAGGGGAGCCGGC,
Slc1A4 Deficiency,congenital and chromosomal,bhrama,44,1,yes,autosomal recessive  ,9,Nervous system,SLC1A4,TCGCCAGGGCTCAGGCCTGGGAACGGAAGAGGTTAAAATCCAGTGGCTTGTGTTTCAGCTTTGGTTACGTGGCAGAAACCAACTGGAAGTGGTGGCGTGAGAGCTCTG,
Unilateral Microphthalmia,congenital and chromosomal,bhrama,98,9,yes,X-linked recessive,37,Head or neck,VSX2,CTGGCCCCGGTGATTGGCTGCTCAGCTCTGACCCCACTTGGGCTGCCGCCTGGTTGGATAAAAGGGGAATCTCCTTGGGCTCCAGAGCATTAGACACCGGAGGGGGCA,
Mef2C Deletion,congenital and chromosomal,bhrama,71,1,yes,autosomal dominant  ,225,Skeletal system,MEF2C,GCTTTAGCTCCATATAGTTTATTTCCTTGATAAAATTAGAATATGATAGTTCTTATGAAACTGACTTGCTGTTAGAGTGGTATTTAATTTTTCTTTTTTGTTCAGCAG,
Syngap1 Syndrome,congenital and chromosomal,bhrama,12,1,yes,autosomal dominant  ,127,Nervous system,SYNGAP1,CTCTCACAATCTGGGCCTCCCGGAGTAGGGGTGGGGGCTGCAGAGTCTCTCCCTCCTCCTCCTCCTCCTGCTCTCTTCGCTCTCGCTCGCTCCCCCGCCCCCCCTCTC,
Primary Congenital Lymphedema,congenital and chromosomal,bhrama,11,4,yes,autosomal dominant  ,11,Cardiovascular system,FOXC2,GCGCCCCTGCTCGGCCCGAGCGCCGCCGCCCGCGCACCCTCGCCCCGGAGGCTGCCAGGAGCCCGGGGCCGCCCCTCCCGCTCCCCTCCTCTCCCCCTCTGGCTCTCT,
Rieger Syndrome,congenital and chromosomal,bhrama,20,6,yes,autosomal dominant  ,32,Head or neck,PTCH1,TTTTGTTCATTTCTGGCGTTGCCATGCTGCTGTGTCGGGCACACGGAGGGTGGCGCGATCCACCCTGTCACAGCGCGTGTTCCCGTTTCCTCTTGATCTCCCAGGTAT,
15Q24 Microdeletion Syndrome,congenital and chromosomal,bhrama,112,1,yes,sporadic,8,Head or neck,SIN3A,GGTAACAGAGAAGCGGCCGCGGCGGTAGAGGCGGCGGAGACGGTTTCTCCATCTTCCCCCCTCCCCTTCCCCCCTCGGAGTTTCCCTCCCTCCCTCCCTCCCTCCTTC,
Satb2-Associated Syndrome,congenital and chromosomal,bhrama,60,1,yes,autosomal dominant  ,49,Head or neck,SATB2,TGTGGCTGTGGTGCAGCGCTCTGCCACTGGCCTGAACGTCTATCACGTGTATGAGCGGTTTTCCCTCTTTTTTCTCCCTCCCCCTTCCTCCCCCCACCCCCTCCCTAG,
Alagille Syndrome,congenital and chromosomal,bhrama,114,1,yes,autosomal dominant  ,100,Skeletal system,JAG1,CCCTTCCAAGTTCCTCCTCGCACTACCCCCTCCCCAGCAACGTGAAGGGGAGGGGCGTGCCCAGGGTGAGCACGCCCTCTCATGAATATTAATAAGCGCGCATGCGCC,
Arteriovenous Malformation,congenital and chromosomal,bhrama,3,3,yes,autosomal dominant  ,27,Cardiovascular system,EPHB4,TGCCGCGAGGAACAGCGAGAAGTGGAGGCCGAAAGCGAAGGAGAGATAGTGACTGTCAGAAAGAGAAACGGAGGTGGACAGAGAGTGGAGGAGAGATAGGTGAGAGAC,
Cardiofaciocutaneous Syndrome,congenital and chromosomal,bhrama,233,4,yes,autosomal dominant  ,127,Head or neck,BRAF,TGGCCCAGGCGCCCTCCGCCCGCGGCGCCGCCCGGGCCGCTCCTCCCCGCGCCCCCCGCGCCCCCCGCTCCTCCGCCTCCGCCTCCGCCTCCGCCTCCCCCAGCTCTC,
Chiari Malformation,congenital and chromosomal,bhrama,19,1,no,sporadic,1,Nervous system,MBP,GATTCTGCTGATGAACAGAAAAAGAGGCTAAATAGAGTTGCTCGATTTATAATAACCTCATTAATCCAAAGATTTTTGTTTTGTATGTGTTTAAATAATAATTAAAAC,
Neurofibromatosis Type 1,congenital and chromosomal,bhrama,20,3,yes,autosomal dominant  ,52,Head or neck,NF1,CCTCCAGGAGGACTCGCTTTTTCATTAATGAAACCGGCCGGCGCGGGCGCATGCGCGGCAGGCCGCCTTCCCTCTCGCTTCCCCCTCCCCTTTCCCAGCCGCGCTCTC,
Pachygyria,congenital and chromosomal,bhrama,12,7,yes,autosomal recessive  ,78,Nervous system,TUBA1A,AAAAACCTCACATAGATAATTTTAACTGCAGTTTGAGGTTTAAGCAACAGAAAGTCTTCTAACCCCAGTCCCCTTTCTTCTCCTTCCGCCCCTCCCCAACCCCGCCCC,
Pfeiffer Syndrome,congenital and chromosomal,bhrama,137,2,yes,autosomal dominant  ,39,Skeletal system,FGFR2,TCTCCCAGTGGCCAGCACCCCCTGAAGCCCCCGGTGCGACGCCTTGTGGTTCCACAGCCCCCTCCACAATCATTCCTGTGTCGTCTAGCCTTTTCTTTTGCTTCCCTT,
Arnold Chiari Syndrome,congenital and chromosomal,bhrama,71,1,yes,sporadic,208,Nervous system,DKKÂ 1.00,GCCCCTCCCAGCGCTTTGAAATCCCATCCCGGCTTTGTTGTCTCCCTCCCAAGGGGCCGGAATGCTCCGGGCCCGCGGTATAAAGGCAGCCGCGGTGGCGGTGGCGGC,
Ccm3 Gene Mutation,congenital and chromosomal,bhrama,5,1,yes,autosomal dominant  ,28,Nervous system,PDCD10,CGGACAACGCCTGGTTCCTCTTGGGTCCTTCCGGCGTCGCCGGAGTGAATTGATCCGGGAGTTGAAGAGGGCTGCAAGGTGGGAAGTGAAGTCAGTGCCTCAGTTGCT,
Foxg1 Syndrome,congenital and chromosomal,bhrama,43,1,yes,autosomal dominant  ,81,Nervous system,FOXG1,GGGGGGAGACCAAGAAGTACAGTTGGGAGCGAGGGAGCTTCACCCCCGGGGCGGTGGTTGTTTCTTTTTTCTTTCTTTCTTTTTTCTTTTCCTTTTTTTTTTTTTTTC,
Ichthyosis,congenital and chromosomal,bhrama,1656,6,yes,autosomal recessive  ,864,Integument,TGM1,GCCCCCAGACCTCACCCCTGCTCCCTCCCTAGCATCTTCTCCCCATTTCCCGCCCAGAGGCCTGGCCTCTTCTCTCCGCCCCCTACAGCAGTTTGGCCCCTCCCTCCC,
West Syndrome,neurological,netra,143,29,yes,autosomal dominant  ,361,Nervous system,ARX,CCGACGCAGCCCGGCCTCTGGCGAGAGCCAATCAGAGGGCGCCTCTCAGCACGTGGAGGAGAGAGACTCCAGAGCTCAGCGCCCGCTGCTCACTACACTTGTTACCGC,
Duane Syndrome,neurological,netra,7,4,yes,autosomal dominant  ,4,Skeletal system,CHN1,GAGACAGAGTGAGTTTAGGAATACAGTACTTAAATACTGTTGCTTGATTTTCATTGGTTATCTCCTTTCTTACGGTGGCCAATCTAATGCAGCCTTCCTTGTGAAATC,
Leber Congenital Amaurosis,neurological,netra,8,44,yes,autosomal recessive  ,8,Skeletal system,RPE65,GCAACTTCTGTTCCCCCTCCCTCAGCTGAAGGGGTGGGGAAGGGCTCCCAAAGCCATAACTCCTTTTAAGGGATTTAGAAGGCATAAAAAGGCCCCTGGCTGAGAACT,
Alternating Hemiplegia Of Childhood,neurological,netra,9,4,yes,autosomal dominant  ,1,Nervous system,ATP1A2,TAGGGCCAGTGGCTAAAGGGGCGGGAGGGGAGGAGTCCTCAGGGATCCTGTTTCAACAAACGTTTCTTTCGGAGGAGGGGAAGGCGGGGGAGAGGGGGAGAAGGACCT,
Amyotrophic Lateral Sclerosis,neurological,netra,12,38,yes,autosomal recessive  ,13,Nervous system,SOD1,GGGGAGTCTCCGGCGCACGCGGCCCCTTGGCCCCGCCCCCAGTCATTCCCGGCCACTCGCGACCCGAGGCTGCCGCAGGGGGCGGGCTGAGCGCGTGCGAGGCGATTG,
Becker Muscular Dystrophy,neurological,netra,25,1,yes,X-linked recessive  ,75,Musculature,DMD,CACGGCCCCGCCCCGTCTGCCCGCAGCGCCCCCTCCCCGGCCCGCCCGCGCCGGCTCCTCCGCAGTGCTTTCAGCTGTGAGCTTGGGCGGCGGCGGCGGCGGCGCTCC,
Centronuclear Myopathy,neurological,netra,202,3,yes,xlinked,219,Musculature,DNM2,CCACCTCACGGTCCACAACATCGCCTACCAGGTGAGCCAGTGCCCGGGGCAAGGTGGGCGGGGGTGTCCTAGGTGCGTATGCCCCACGCTGACCTCCCCTCCCCGCAG,
Charcot-Marie-Tooth,neurological,netra,14,28,yes,autosomal dominant  ,7,Nervous system,MPZ,CCCACCACCTCTCAACTGCACATGCCAGGCTGCAATTGGTTACTGGCTGAGGACAGCCCCCTCATGCTGGGGCCCTAGGGGATTTTAAGCAGGTTCCAGGAACCCCCC,
Duchenne Muscular Dystrophy,neurological,netra,27,3,yes,X-linked recessive  ,1143,Nervous system,DMD,CACGGCCCCGCCCCGTCTGCCCGCAGCGCCCCCTCCCCGGCCCGCCCGCGCCGGCTCCTCCGCAGTGCTTTCAGCTGTGAGCTTGGGCGGCGGCGGCGGCGGCGCTCC,
Dystonia 27,neurological,netra,9,1,yes,autosomal recessive  ,7,Nervous system,COL6A3,CCAAGTGTCGCTTGTAATTCTATTAAATAACTGGTTTAATTGTGTGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT,
Facioscapulohumeral Muscular Dystrophy,neurological,netra,7,5,yes,autosomal dominant  ,21,Musculature,SMCHD1,GGCGATAGGCGCTGGGCCCGGGCCCGGTGAGGAGCGCGCCGCGCGTCCCCTTCTCCTCAGGAGTGGCGGGCCGCGGAAGTGACGTGGTGCACGGGCAGGAGCGCGTTT,
Friedreich Ataxia,neurological,netra,71,3,yes,autosomal recessive  ,21,Nervous system,FXN,CCGGCGGCCAAGCAGCCTCAATTTGTGCATGCACCCACTTCCCAGCAAGACAGCAGCTCCCAAGTTCCTCCTGTTTAGAATTTTAGAAGCGGCGGGCCACCAGGCTGC,
Giant Axonal Neuropathy,neurological,netra,42,1,yes,autosomal recessive  ,14,Nervous system,GAN,TCTCCAGCAGCGGAGGCGAGAAGGCGGGGAGCGACGGTGCGGGGGCGTCGCGGAGAAATGACTTCATGACGCGGCTTCTTAAAGGCGCCGGCCCAGCGCGCCGCGGAT,
Hereditary Spastic Paraplegia,neurological,netra,37,29,yes,autosomal dominant  ,13,Nervous system,SPAST,GACGCGCCGTGCGCGCGCGCGCCGGAGAAAAACACGGGAAGACGTGCGCGTGCGCGGCCGCCGCTGGGAGCCACCAGGCGGCGGAGAGGACAGCGACAGGAAGGGAGG,
Huntington Disease,neurological,netra,82,4,yes,autosomal dominant  ,48,Nervous system,HTT,GAGTCCGCAGGCTAGGGCTGTCAATCATGCTGGCCGGCGTGGCCCCGCCTCCGCCGGCGCGGCCCCGCCTCCGCCGGCGCAGCGTCTGGGACGCAAGGCGCCGTGGGG,
Inclusion Body Myositis,neurological,netra,63,1,yes,autosomal dominant  ,122,Musculature,GNE,CTGCGCCTCAAAATACCGCCGGGAAGGTGGGGGACGGGGACGGGAGCAGCCAATCACGCGAGCTCTCTCGGGTGGCGTCAGGGCGCGATCGCGGATTCGGCACTCCGG,
Lama Ii Muscular Dystrophy (Merosin Deficient),neurological,netra,63,1,yes,autosomal recessive  ,204,Nervous system,LAMA2,CGTCCTGGGGCCGCGTGCCCATGGAAGGCGAGAGTGGAGGAGTGTCCTCTTTCTCCCCCACCCTCAGGCGGCGGCCCGGCCAAAGCCAGAGGGGGCTGTCTCCTCCTC,
Lennox-Gastaut Syndrome,neurological,netra,74,8,yes,autosomal recessive  ,128,Nervous system,CHD2,TAGATTTTAGTTTCTTTTTTGTAATTAAAAAGTTTAAAAACACTTATTTTTACTTGCTATTGTTTGCTTCATAATTAAGTTTAGAATCTTATTTGTTTTCACCAAAAG,
Nemaline Myopathy,neurological,netra,43,2,yes,autosomal dominant  ,429,Musculature,NEB,TCCTCTAACTTACTCTCTTCCTCCCTTCCCACTCCCAACTGCTCCAAAGCAGGGGGAAAATGACTGATTGATTGCTTTTTTTGTTCTGGATGCTTTCTCATCATACAG,
Neurodegeneration With Brain Iron Accumulation,neurological,netra,11,1,yes,autosomal recessive  ,1,Nervous system,PANK2,TAACCCACCTCTTTCTTTCAGTTGCCATGGAGACAAGCCCCAGTCCTTTCATTCCTTCTGGTACCTCTCTCTCCAACGCAGGCGGAAAGGAGGCGGCTTAGCCCAAAC,
Sepn1 Related Myopathy (Subtype Of Congenital Muscular Dystrophy,neurological,netra,24,4,yes,autosomal recessive  ,50,Musculature,SELENON,TGACCCCGCCCCGGGCTCTGGCCGGGCTGCGAAGCCGGGAACCAGCGACCCCCCGCCCAGCCCCTGCGGCCGCCCCGCCCCTCCCCGCCCCGGCCGCCCCGCCCCCGG,
Spinal Muscular Atrophy,neurological,netra,8,6,yes,autosomal recessive  ,3,Nervous system,SMN1,CTGAGCGACAGGGCGAGGCTCTGTCTCAAAACAAACAAACAAAAAAAAAAGGAAAGGAAATATAACACAGTGAAATGAAAGGATTGAGAGAAATGAAAAATATACACG,
Canavan Disease,neurological,netra,77,2,yes,autosomal recessive  ,66,Nervous system,ASPA,TGGGTCATCCCAAAAATCAAGTACACTTTGGGAAACAGGGAGTTAAAAATCTTTCGGAAGTTAACTTGGTATAAGAGTATGAAAAGCCTCTGTTGCTCTACTTCTGAG,
Kearns-Sayres Syndrome,neurological,netra,34,1,yes,Mitochondrial  ,4,Nervous system,RRM2B,GTAGTTGGAGGTGGCCTGAGGAGCTCAGTTCCCTCAGCGCCCGTAGCTTCGGCGGAGTCTGCGCGATGGGCGACCCGGAAAGGCCGGAAGCGGCCGGGCTGGATCAGG,
Hypokalemic Periodic Paralysis,neurological,netra,4,3,yes,autosomal dominant  ,45,Musculature,CACNA1S,AGGCCTGTGTGTAAGTTCTTCCCCCGACCCACCCCACCCTCCTCAGGGGACAGATTGGGAAGTCACTGGCTGGGCTGGGTGGAATGACAGCTGCCTGGCCTCAGAAGC,
Kennedy's Disease,neurological,netra,24,1,yes,X-linked recessive  ,57,Nervous system,AR,AGGGGAGGGGAGGGAAAAGGAGGTGGGAAGGCAAGGAGGCCGGCCCGGTGGGGGCGGGACCCGACTCGCAAACTGTTGCATTTGCTCTCCACCTCCCAGCGCCCCCTC,
Landau-Kleffner Syndrome,neurological,netra,41,1,yes,autosomal dominant  ,63,Nervous system,GRIN2A,CCGCGGGAGCCCGCGTCCTTCCCTCCCCCTCTCCTACTGCTGGCTCGTCACAAACTCAGCCAGCGCCCCCCCACCCTCGTTACCTCCTCTTTCTCTCCCTACCTCCCT,
Multiple System Atrophy,neurological,netra,195,1,yes,autosomal recessive  ,48,Nervous system,COQ2,AAGATCGAGTTGTAAAAAATTACAACTAAATTTATTGTAATTTTTTTGCCTTTTGCCAATAGAAATCCCTTTTTCATTAAGTATTCCTCCCTAGAGTAAGCGACCACG,
Muscular Dystrophy,neurological,netra,19,9,yes,autosomal dominant  ,8,Musculature,DMD,CACGGCCCCGCCCCGTCTGCCCGCAGCGCCCCCTCCCCGGCCCGCCCGCGCCGGCTCCTCCGCAGTGCTTTCAGCTGTGAGCTTGGGCGGCGGCGGCGGCGGCGCTCC,
Myasthenia Gravis,neurological,netra,50,1,no,sporadic,3,Nervous system,AKAP12,TATGGTCGGACTCAGGAGGAGCCAGGGAGCGCTTGCCTTTCTCCTGCTAATGGGGAGGAGGCTGGAACAAATGTTTGGAGTTAAACACAATCTGCAGGAAAGCAAATG,
Primary Lateral Sclerosis,neurological,netra,7,38,yes,autosomal dominant  ,955,Nervous system,SOD1,GGGGAGTCTCCGGCGCACGCGGCCCCTTGGCCCCGCCCCCAGTCATTCCCGGCCACTCGCGACCCGAGGCTGCCGCAGGGGGCGGGCTGAGCGCGTGCGAGGCGATTG,
Meniere's Disease,neurological,netra,3,1,yes,autosomal dominant  ,3,Head or neck,FAM136A,AGCGGGAGGAGGGCGGTGGGCTCGCGGACACCAGCATGCAGTGGCTCCGTTCGGCCGCCAGGGGGGGGCGTGGGCCCTGGAAGGGCAGGCGGCGAAGGGCGGCGAAGG,
Vestibular Disorder,neurological,netra,5,1,no,autosomal dominant  ,3,Head or neck,COCH,GGGGGCGAAGGCGGAGCTGGAAGTCGCCGCCGGGCCCCGGGGGACCGGCTCCCGCGCTTCCTCCCGCGCCCCCCGCACAGTGCTCATGCGCACGGCCCAGCCTTTATA,
Cdkl5 Deficiency Disorder,neurological,netra,58,1,yes,X-linked dominant,213,Nervous system,CDKL5,AAAACCTGAGGTGCTTTCCCATTGGTCCGAACGGGCCGGCTGGGGCGGGGCAGTTAGCAAAATAGGCTGCGCGTTCGCTTCTGCTAGAGGGCGGGGCCGGAGGTTTCG,
Corticobasal Syndrome (or Corticobasal Degeneration),neurological,netra,78,1,no,sporadic,1341,Nervous system,TBK1,ACGGGGTGTCTCCAGACATCCCCCTCATTACCGTGGCCGCGGAAGCCGACTCGGCAGTTGCCGCCGCGGCTGTGGTGACTACCAGACGGGCCATAGGCGTGCGCACGC,
Guillain-Barre Syndrome,neurological,netra,21,1,yes,sporadic,1,Nervous system,PMP22,CGGTCGGGCTGCGGGCGCTGGGCCAGGCCGGGCCTTCCGCTAGTGCGCGGGACCCTCCCTCTGCGCGCGCCTCCGTCGCTCGGCCCAGTGCGTTCGGCCTCACGCCCA,
Limb Girdle Muscular Dystrophy,neurological,netra,809,5,yes,autosomal dominant  ,1888,Musculature,CAPN3,AATCCGTACTTGTAGACTGTGAATTTTATAAAATGAAATATTTTTAAATTCTACCTTGAAATTTTCTTATATGAATACTGCTTCCCTGAGCGTGCTGCTCTGTTACAG,
Neuromyelitis Optica,neurological,netra,15,1,no,sporadic,2,Nervous system,AQP4,TGTGCAAATCACGCCTGGCAGCCCCTGCCCACAGTACCCGAAGATGGCAGGCCTTGTTCCCTTCACCTAAATTCATAAACCTGGGTGTAGTGGCTTCTGATGCTGATT,
Ohtahara Syndrome,neurological,netra,1744,19,yes,sporadic,2442,Nervous system,STXBP1,CCGCATCTCGGGGGGCGGGGTTGAGCCTCCGGGCCGCAGTGCGATTGGCGGAGGCGAGTGGGTGACGCCAACGGCCGGCGCGAGGCCCCGCCCCCGGCTTGCCCCGCC,
Stxbp1 Encephaolopathy With Epilepsy,neurological,netra,15983,3,yes,autosomal dominant  ,13372,Nervous system,STXBP1,CCGCATCTCGGGGGGCGGGGTTGAGCCTCCGGGCCGCAGTGCGATTGGCGGAGGCGAGTGGGTGACGCCAACGGCCGGCGCGAGGCCCCGCCCCCGGCTTGCCCCGCC,
Alexander Disease Adult Onset,neurological,netra,28,1,yes,autosomal dominant  ,1,Immune system,GFAP,GGGCACAGTGACCTCAGTGGGGTGAGGGGAGCTCTCCCCATAGCTGGGCTGCGGCCCAACCCCACCCCCTCAGGCTATGCCAGGGGGTGTTGCCAGGGGCACCCGGGC,
Osteopetrosis,neurological,netra,666,2,yes,autosomal dominant  ,176,Skeletal system,CLCN7,CTCCCTCCGCACAAGGGTTTGGTTTGGTTTTTAAAATTGAAACATGATTCAAATACCGTAAAACTCATCGTTTTAAAGAGGGCAGTTCAGCGGCGTTTCTCACGTTCA,
Atp6V1A Gene Mutation,neurological,netra,31,1,yes,autosomal recessive  ,2,Head or neck,ATP6V1A,ATATTCAAGGGATCCGTAAAAATTCAGGCCCCCCGAGATGTAGAGCGCTGGGATGGAGGAGGCAGGGCGGAGCTCGACGTCATGTGACTGGTTGGGCCCGCCCCCCCC,
Cacna1S,neurological,netra,9,1,yes,autosomal dominant  ,12,Nervous system,CACNA1S,AGGCCTGTGTGTAAGTTCTTCCCCCGACCCACCCCACCCTCCTCAGGGGACAGATTGGGAAGTCACTGGCTGGGCTGGGTGGAATGACAGCTGCCTGGCCTCAGAAGC,
Cataplexy,neurological,netra,29,8,yes,sporadic,27,Nervous system,HCRT,GCAGGCTAATCTTAGACTTGCCTTTGTCTGGCCTGGGTGTGGACGCAAGTGCCTGTCAATTCCCCGCCACCTCAGAGCACTATAAACCCCAGACCCCTGGGAGTGGGT,
Communicating Hydrocephalus,neurological,netra,7,1,no,autosomal dominant  ,3,Nervous system,SERPINA3,TGAACAGATACTTAGAGGTTGATGCCCATAGGCAGAAGCTTTGCCATTTGCTATGATGACTTCACCTGCCCCTAGTGGCCTGGTGATGCCTGGTGTCTCCCCTGCAGA,
Dravet Syndrome,neurological,netra,18,8,yes,autosomal dominant  ,349,Nervous system,SCN1A,GGAGAAAACAGACTTTAAATCCTCTAGCTCATGTTTCATGACAAGAATTTATTTATATTAACATCTCTTAGTCCACTCTTTAAAATATCTGTATTCCTTTTATTTTAG,
Dysautonomia,neurological,netra,0,2,yes,autosomal recessive  ,4,Nervous system,CPT2,TTATATGTCAATGACCTTCAGCACGGATTACTAACAACAGTAACATCCGTTACCGTTTACTGCTTTCCTATTAAGCACCATGCACTGTGCATAACATGTTATCTTTAT,
Familial Dysautonomia,neurological,netra,57,2,yes,autosomal recessive  ,59,Skeletal system,CPT2,TTATATGTCAATGACCTTCAGCACGGATTACTAACAACAGTAACATCCGTTACCGTTTACTGCTTTCCTATTAAGCACCATGCACTGTGCATAACATGTTATCTTTAT,
Myotonic Muscular Dystrophy,neurological,netra,137,1,yes,autosomal dominant  ,202,Nervous system,DMPK,CAGGTCGGGATCGGGGCCGGGGCCGGGGCCGGGATGCGGGCCGGTGGCAACCCTTGGCATCCCCTCTCGTCCGGCCCGGACGGACTCACCGTCCTTACCTCCCCACAG,
Narcolepsy,neurological,netra,34,1,yes,autosomal dominant  ,30,Nervous system,HCRT,GCAGGCTAATCTTAGACTTGCCTTTGTCTGGCCTGGGTGTGGACGCAAGTGCCTGTCAATTCCCCGCCACCTCAGAGCACTATAAACCCCAGACCCCTGGGAGTGGGT,
Scn8A,neurological,netra,10,19,yes,autosomal dominant  ,69,Nervous system,SCN8A,GCGGGGCGGGCGGGGGGCCCGGCAGTAGGGGCGCGCGCGCGGTGGCGCGCGGCGGGCGCGAGTCATCAATTATGCAAGGACTCGGGCGGTGCGGGGGGCGGGCGCGGG,
Spinocerebellar Ataxia,neurological,netra,65,2,yes,autosomal dominant  ,5,Nervous system,ATXN1,GAGCGAGCGAGCGCGAGAGAGCGCGAGGGAGGGAGGGAGGGCGGGCGGGCGGAGGGAGGAGGGAGGGGAGGGGAGCGGGAGGAGGGGGAGGAGGAGGAGGAGGAGGAG,
Trpv4,neurological,netra,119,1,yes,autosomal dominant  ,39,Skeletal system,TRPV4,GTCCACGTGGGAGGGGGCTTCCTGGAGCCCCCGCCCCTGGCCGGGTTCTGCCTGACTCCCCTTTCATTCCCTTGCAGGCTGAGCAGTGCAGACGGGCCTGGGGCAGGC,
Tubulinopathy Tuba1A,neurological,netra,0,1,yes,autosomal dominant  ,112,Nervous system,TUBA1A,AAAAACCTCACATAGATAATTTTAACTGCAGTTTGAGGTTTAAGCAACAGAAAGTCTTCTAACCCCAGTCCCCTTTCTTCTCCTTCCGCCCCTCCCCAACCCCGCCCC,
Microvillus Inclusion Disease,digestive,agni,15,2,yes,autosomal recessive  ,17,Digestive system,MYO5B,GCGCCAGAGAGCCTGACCTGGGAGGAGTCTTGCCTTGAGAGAATGGACTCTGACTCATCATCTCCCACTTCCTGAGTTCCAGAGCAGGTGGCAACAGCCTGTGAAGAG,
Primary Biliary Cholangitis,digestive,agni,33,8,yes,sporadic,32,Digestive system,IRF5,GCGCCCTCATTTGTGTGCAGCCCCGGAGGACCAGAGTGGGGAAGCACCCCACCCTCTCCCAGGGCCCAACTGAGCACTGCAGCGGGAGGTACGGGGTTGTCAAATGAC,
Short Bowel Syndrome,digestive,agni,8,1,no,autosomal recessive  ,5,Digestive system,CLMP,AGCTCACGCTTCTCCCCGACCGGCCCCCACCGCAAACCCCAAACGCCGCGCGGGAGGGAGGGAGGGAAGGAGGGAACAGCGAGAGAGAGAGGGAGGGGCTGCGGTAGG,
Autoimmune Pancreatitis,digestive,agni,1,1,no,autosomal dominant  ,2,Immune system,IL33,AACTCTGTTGGCTCTTTACATGAGATTTCAAGCCTGCTAAAATCTCACCCGCCCAGATCTCCCTTCTAAGGCAATTTGGGTCTCTGCCAAACTTTGGCTAATAAAAAG,
Chronic Intestinal Pseudo-Obstruction,digestive,agni,43,3,yes,sporadic,11,Digestive system,ACTG2,CCCCCTTCCCTACCCCCAAGGCGATTTATTGAAAAAACCACCTTATATGGTAATATTGCTAACACACCGTCAGCTGGCCTTTTTAGGGACTTTGTTTAAAGAAGATCC,
Sickle Cell Disease,blood,rishi,39,2,yes,autosomal recessive  ,101,blood,HBB,CCTCACCCTGTGGAGCCACACCCTAGGGTTGGCCAATCTACTCCCAGGAGCAGGGAGGGCAGGAGCCAGGGCTGGGCATAAAAGTCAGGGCAGAGCCATCTATTGCTT,
Moyamoya,circulatory,rishi,64,4,yes,autosomal recessive  ,60,Cardiovascular system,GUCY1A1,TTTTCTTTTTAAGTGTGCCAAATTTTCCTGGAGTCCCCTCCAATTTTTTTCTTTCTCTCTCTCTCTCTCTTTTTTTTTTTTTGTCCCCTGCCCCTAGGTCTCTGTCTC,
Cnot3 Mutation,circulatory blood,rishi,40,1,yes,autosomal dominant  ,7,Head or neck,CNOT3,AGGGCGCATCCCTGCCAGGAACCAATAGAAAGCCTCCAAGGGTCAGGAGCGACGTTCAGCAGGAGCAATGACTGGCCTATATTCGGGACTCGGGGGCGGGTCGGCGCC,
Hemophilia,circulatory blood,rishi,19,1,no,X-linked recessive  ,181,Blood and blood-forming tissues,F8,GCCGCCGCCGCCCAGGCCTGCAGCCGCTGCCGCCATGCTCGCCGCCCCAAGCACTTCCCGACGCGCCGCCGCAGCTGGCGGGCGGGCCGGGGCGGGGCGACGTGCCCT,
Thalassemia,circulatory blood,rishi,190,1,yes,autosomal recessive  ,370,Blood and blood-forming tissues,MIR144,GAGCTGTAGAGCAGGGAGCAGGAAGCTGTGTGTGTCCAGCCCTGACCTGTCCTGTTCTGCCCCCAGCCCCTCACAGTGCTTTTCAAGCCATGCTTCCTGTGCCCCCAG,
Cadasil,circulatory blood,rishi,82,1,yes,autosomal dominant  ,62,Nervous system,NOTCH3,CCGGGAGGCCGGGCGGGGGGCGGGGGCGCGCTGGGCCGGCCCCGGGGCGGGGCGAGCCTTCGAGGGCTGGGGGCGGGGCGGCCCGGCCGCCTCACTTCGGCGAAGTTG,
Pulmonary Hypertension,circulatory blood,rishi,239,2,yes,autosomal dominant  ,486,Cardiovascular system,BMPR2,AGAGACAGACAGGGCCGGGAAGAGCCGGAGACTGAGGAGGAGGCGGAGGCGGCGGCGGAGGCGGGGCGACTCCGGTGACCGGGAGCGCCGCAGACTGGCAGCTGCGGC,
Idiopathic Thrombocytopenia Purpura,cirulatory,rishi,12,1,no,autosomal dominant  ,3,Blood and blood-forming tissues,SOCS1,GGCGGGGCCGGCAGGGGGCGGGGCCTCCCGCCGTCGCCAGCCCCGCCTCCGAGCCGGTTTAAAAGACTGGCGCAGGGGCGGGCGCCGAACAGAGCGAGCTGCGGCCGT,
Catecholaminergic Polymorphic Ventricular Tachycardia,cirulatory,rishi,5,7,yes,autosomal dominant  ,6,Cardiovascular system,CASQ2,ATTTATTTTTAGCCTGAAACAACTGCATCCTAAAAATGGAGTTCCTAATGAGACAGAGGCTGAGCAGAGCTATGTAAGGTATCTGGGGCTTGGCCTCCCAGCCTCCCT,
Long Qt Syndrome,cirulatory,rishi,5,12,yes,Heterogeneous,92,Cardiovascular system,KCNH2,GCTGCAGGAGCCTGGGCGGGCTGCGGGGGAGGGGGCCGCTGGCTGGGCACCGGCGGGGCGGGGGAGCCTAGTGTGGCGGGGTGGGGGTGGGGACCTGGTAGAAGGAGG,
Postural Orthostatic Tachycardia Syndrome,cirulatory,rishi,1,1,no,autosomal dominant  ,1,Nervous system,SLC44A1,GAGGGACTGGGCGCGGGAGGCGGGAGGCGGGGGGACAGAGGGAGGCGCCGCCGCCGCCGCCGCCCGCCCCTTTCCGCTGGGGAGCAGCTGCTGCAGCAGGAGCAGAGC,